
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Gpr35 Expression Mitigates Neuroinflammation and Enriches Gut Lactobacillus to Relieve Parkinson’s Disease - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15251AF28AEEDA43051AF2002D3799D4.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="research">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376290/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Research">
<meta name="citation_title" content="Gpr35 Expression Mitigates Neuroinflammation and Enriches Gut Lactobacillus to Relieve Parkinson’s Disease">
<meta name="citation_author" content="Tianyu Meng">
<meta name="citation_author_institution" content="Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School (SIGS), Tsinghua University, Shenzhen 518055, China.">
<meta name="citation_author_institution" content="Key Laboratory of Industrial Biocatalysis, Ministry of Education, Tsinghua University, Beijing 100084, China.">
<meta name="citation_author_institution" content="Key Lab of Active Proteins and Peptides Green Biomanufacturing of Guangdong Higher Education Institutes, Tsinghua Shenzhen International Graduate School, Shenzhen 518055, China.">
<meta name="citation_author" content="Yufei Zhang">
<meta name="citation_author_institution" content="College of Veterinary Medicine, Jilin University, Changchun 130062, China.">
<meta name="citation_author" content="Shoupeng Fu">
<meta name="citation_author_institution" content="College of Veterinary Medicine, Jilin University, Changchun 130062, China.">
<meta name="citation_author" content="Shaohua Ma">
<meta name="citation_author_institution" content="Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School (SIGS), Tsinghua University, Shenzhen 518055, China.">
<meta name="citation_author_institution" content="Key Laboratory of Industrial Biocatalysis, Ministry of Education, Tsinghua University, Beijing 100084, China.">
<meta name="citation_author_institution" content="Key Lab of Active Proteins and Peptides Green Biomanufacturing of Guangdong Higher Education Institutes, Tsinghua Shenzhen International Graduate School, Shenzhen 518055, China.">
<meta name="citation_publication_date" content="2025 Aug 25">
<meta name="citation_volume" content="8">
<meta name="citation_firstpage" content="0846">
<meta name="citation_doi" content="10.34133/research.0846">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376290/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376290/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376290/pdf/research.0846.pdf">
<meta name="description" content="Parkinson’s disease (PD) is associated with gut–brain axis and gut microbiota alterations, but the functioning mechanism remains to be elucidated. In this study, we identified G protein-coupled receptor 35 (Gpr35) as a key regulator for the ...">
<meta name="og:title" content="Gpr35 Expression Mitigates Neuroinflammation and Enriches Gut Lactobacillus to Relieve Parkinson’s Disease">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Parkinson’s disease (PD) is associated with gut–brain axis and gut microbiota alterations, but the functioning mechanism remains to be elucidated. In this study, we identified G protein-coupled receptor 35 (Gpr35) as a key regulator for the ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376290/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12376290">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.34133/research.0846"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/research.0846.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12376290%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12376290/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12376290/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376290/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-research.png" alt="Research logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Research" title="Link to Research" shape="default" href="https://spj.sciencemag.org/research/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Research (Wash D C)</button></div>. 2025 Aug 25;8:0846. doi: <a href="https://doi.org/10.34133/research.0846" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.34133/research.0846</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Research%20(Wash%20D%20C)%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Research%20(Wash%20D%20C)%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Research%20(Wash%20D%20C)%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Research%20(Wash%20D%20C)%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Gpr35 Expression Mitigates Neuroinflammation and Enriches Gut <em>Lactobacillus</em> to Relieve Parkinson’s Disease</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meng%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Tianyu Meng</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Tianyu Meng</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School (SIGS), 
Tsinghua University, Shenzhen 518055, China.</div>
<div class="p">
<sup><sup>2</sup></sup>Key Laboratory of Industrial Biocatalysis, Ministry of Education, 
Tsinghua University, Beijing 100084, China.</div>
<div class="p">
<sup><sup>3</sup></sup>Key Lab of Active Proteins and Peptides Green Biomanufacturing of Guangdong Higher Education Institutes, 
Tsinghua Shenzhen International Graduate School, Shenzhen 518055, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meng%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tianyu Meng</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yufei Zhang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yufei Zhang</span></h3>
<div class="p">
<sup><sup>4</sup></sup>College of Veterinary Medicine, 
Jilin University, Changchun 130062, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yufei Zhang</span></a>
</div>
</div>
<sup>4,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Shoupeng Fu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Shoupeng Fu</span></h3>
<div class="p">
<sup><sup>4</sup></sup>College of Veterinary Medicine, 
Jilin University, Changchun 130062, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shoupeng Fu</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Shaohua Ma</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Shaohua Ma</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School (SIGS), 
Tsinghua University, Shenzhen 518055, China.</div>
<div class="p">
<sup><sup>2</sup></sup>Key Laboratory of Industrial Biocatalysis, Ministry of Education, 
Tsinghua University, Beijing 100084, China.</div>
<div class="p">
<sup><sup>3</sup></sup>Key Lab of Active Proteins and Peptides Green Biomanufacturing of Guangdong Higher Education Institutes, 
Tsinghua Shenzhen International Graduate School, Shenzhen 518055, China.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shaohua Ma</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup><sup>1</sup></sup>Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School (SIGS), 
Tsinghua University, Shenzhen 518055, China.</div>
<div id="aff2">
<sup><sup>2</sup></sup>Key Laboratory of Industrial Biocatalysis, Ministry of Education, 
Tsinghua University, Beijing 100084, China.</div>
<div id="aff3">
<sup><sup>3</sup></sup>Key Lab of Active Proteins and Peptides Green Biomanufacturing of Guangdong Higher Education Institutes, 
Tsinghua Shenzhen International Graduate School, Shenzhen 518055, China.</div>
<div id="aff4">
<sup><sup>4</sup></sup>College of Veterinary Medicine, 
Jilin University, Changchun 130062, China.</div>
<div class="author-notes p">
<div class="fn" id="corr1">
<sup>*</sup><p class="display-inline">Address correspondence to: <span>ma.shaohua@sz.tsinghua.edu.cn</span></p>
</div>
<div class="fn" id="afn1">
<sup>†</sup><p class="display-inline">These authors contributed equally to this work.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 25; Revised 2025 Jul 27; Accepted 2025 Jul 28; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025 Tianyu Meng et al.</div>
<p>Exclusive licensee Science and Technology Review Publishing House. No claim to original U.S. Government Works. Distributed under a <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License (CC BY 4.0)</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12376290</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Parkinson’s disease (PD) is associated with gut–brain axis and gut microbiota alterations, but the functioning mechanism remains to be elucidated. In this study, we identified G protein-coupled receptor 35 (Gpr35) as a key regulator for the gut–brain association under the PD context. It investigated the impact of Gpr35 deficiency on motor function, neuroinflammation, and dopaminergic neurodegeneration, using the Gpr35 knockout (Gpr35<sup>−/−</sup>) and wild-type (WT) mice in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model, and Gpr35 up-/down-regulation on reverse neuroinflammation, oxidative stress, and neuronal apoptosis using Gpr35 agonist kynurenic acid (KYNA) and small interfering RNA in microglial and dopaminergic cell models. It was confirmed that Gpr35 may prevent PD by modulating neuroinflammation and gut microbiota and metabolite composition, specifically through enriching <em>Lactobacillus</em>, and substantially regulating tyrosine metabolism, neuroactive ligand–receptor interaction, and tryptophan metabolism pathways, thereby inhibiting the progression of PD. Our findings highlight the potential of targeting Gpr35 to influence both the gut microbiota and central nervous system, offering new insights into the treatment of PD.</p></section><section id="sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Parkinson’s disease (PD) is a progressive neurodegenerative disorder predominantly affecting aging populations, characterized by the loss of dopaminergic neurons and the pathological accumulation of Lewy bodies in the substantia nigra (SN) pars compacta region [<a href="#B1" class="usa-link" aria-describedby="B1">1</a>]. While the precise etiology of PD remains multifaceted, around 10% of cases are associated with genetic factors like α-synuclein (α-syn) gene alterations, whereas the majority (90%) are idiopathic, with multifactorial causes involving genetic susceptibility, environmental exposures, and aging [<a href="#B2" class="usa-link" aria-describedby="B2">2</a>]. Recent studies have identified several pathological mechanisms contributing to PD pathogenesis, including impaired mitochondrial function, elevated oxidative stress levels, abnormal protein accumulation, and chronic inflammatory responses within neural tissue [<a href="#B3" class="usa-link" aria-describedby="B3">3</a>–<a href="#B6" class="usa-link" aria-describedby="B6">6</a>]. Emerging research highlights neuroinflammation as a central mechanism driving PD advancement, with immune system dysregulation intensifying the interplay between genetic predispositions and environmental triggers [<a href="#B7" class="usa-link" aria-describedby="B7">7</a>].</p>
<p>Recent investigations into the gut–brain axis have highlighted the critical involvement of intestinal microorganisms in PD development [<a href="#B8" class="usa-link" aria-describedby="B8">8</a>]. PD patients frequently exhibit gut microbiota dysbiosis, marked by reduced beneficial bacteria (e.g., <em>Faecalibacterium</em>) and increased potentially pathogenic species [<a href="#B9" class="usa-link" aria-describedby="B9">9</a>–<a href="#B11" class="usa-link" aria-describedby="B11">11</a>]. Such dysregulation results in diminished synthesis of short-chain fatty acids (SCFAs), which subsequently compromises intestinal barrier function and facilitates the translocation of pro-inflammatory factors into the central nervous system (CNS) [<a href="#B12" class="usa-link" aria-describedby="B12">12</a>]. Dysregulated gut microbiota and metabolites may disrupt intestinal epithelial barrier function, increase permeability, and trigger neuroinflammation, thereby contributing to dopaminergic neuron degeneration [<a href="#B8" class="usa-link" aria-describedby="B8">8</a>]. Microglia, the key immune cells of the CNS, are important mediators of neuroinflammation and synaptic regulation [<a href="#B13" class="usa-link" aria-describedby="B13">13</a>]. Contemporary findings reveal that intestinal flora substantially modulates microglial behavior and CNS immune responses, highlighting promising intervention strategies through microbial manipulation for neurological disorders [<a href="#B14" class="usa-link" aria-describedby="B14">14</a>].</p>
<p>G protein-coupled receptors (GPCRs) are widely recognized as the most prominent group of therapeutic targets, playing critical functions in both disease mechanisms and treatment strategies [<a href="#B15" class="usa-link" aria-describedby="B15">15</a>,<a href="#B16" class="usa-link" aria-describedby="B16">16</a>]. As a class A rhodopsin-like orphan GPCR, G protein-coupled receptor 35 (Gpr35) has been implicated in multiple disease pathways, including gastrointestinal dysfunction, cardiovascular pathology, and oncogenesis [<a href="#B17" class="usa-link" aria-describedby="B17">17</a>–<a href="#B19" class="usa-link" aria-describedby="B19">19</a>]. Gpr35 exhibits high expression levels in gastrointestinal epithelial cells (stomach, small intestine, and colon) as well as immune cells including dendritic cells and macrophages. Through these cellular distributions, it plays a crucial role in preserving intestinal equilibrium while integrating metabolic, immunological, and microbiological signals [<a href="#B20" class="usa-link" aria-describedby="B20">20</a>]. Notably, Gpr35 expression is increased under inflammatory and hypoxic conditions, such as myocardial infarction and inflammatory bowel disease [<a href="#B21" class="usa-link" aria-describedby="B21">21</a>,<a href="#B22" class="usa-link" aria-describedby="B22">22</a>]. As an endogenous ligand of Gpr35, kynurenic acid (KYNA) has been well documented for its role in tryptophan metabolism and its implications in neurological disorders [<a href="#B23" class="usa-link" aria-describedby="B23">23</a>]. Despite its established role in immune regulation, the involvement of Gpr35 in PD remains unexplored.</p>
<p>Given the critical role of Gpr35 in immune modulation and its expression in the gut epithelium, coupled with the established significance of the gut–brain axis in PD regulation [<a href="#B8" class="usa-link" aria-describedby="B8">8</a>], our study provides the first evidence suggesting that Gpr35 could modulate PD progression via microbiota–neuroimmune crosstalk. Therefore, we investigate the role of Gpr35 in PD pathogenesis, focusing on its impact on neuroinflammation, dopaminergic neurodegeneration, and gut microbiota composition. Our data suggest that Gpr35 deficiency exacerbates PD-related motor deficits, neuroinflammation, and dopaminergic neuron loss, while activation of Gpr35 by its agonist KYNA exerts neuroprotective and anti-inflammatory effects. Furthermore, we reveal that Gpr35 modulates gut microbiota composition, particularly affecting <em>Lactobacillus</em> abundance, which may contribute to PD pathogenesis. These results position Gpr35 as a promising therapeutic target for PD, warranting further exploration of its molecular mechanisms and clinical potential.</p></section><section id="sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="sec3"><h3 class="pmc_sec_title">Gpr35 knockout (Gpr35<sup>−/−</sup>) exacerbates the progression of PD and neuroinflammation in the SN</h3>
<p>Firstly, we compared the behavioral performance between the wild-type (WT), negative control (WN) group and the Gpr35<sup>−/−</sup>, nontreated (GN) group. Figure <a href="#F1" class="usa-link">1</a>A illustrates the experimental workflow for animal studies. The analysis revealed comparable body weight fluctuations between groups (Fig. <a href="#F1" class="usa-link">1</a>B), with no statistically significant variations observed, movement trajectories (Fig. <a href="#supplementary-material-1" class="usa-link">S1</a>A), or other quantitative parameters [including the time movement in the central area (Fig. <a href="#F1" class="usa-link">1</a>D) and total travel distance (Fig. <a href="#F1" class="usa-link">1</a>C)] in the open-field test and time it took the mouse to get to the bottom of the pole in the pole test (Fig. <a href="#F1" class="usa-link">1</a>E). However, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) injection led to decreased weight growth (Fig. <a href="#F1" class="usa-link">1</a>B) and motor dysfunction (Fig. <a href="#F1" class="usa-link">1</a>C to E) in both WT and Gpr35<sup>−/−</sup> mice, with more pronounced impairments observed in the Gpr35<sup>−/−</sup>-MPTP (GM) group compared to the WT-MPTP (WM) group. Specifically, Gpr35<sup>−/−</sup> PD mice exhibited a shorter total travel distance in the open-field test (Fig. <a href="#F1" class="usa-link">1</a>C) and longer times in the pole test (Fig. <a href="#F1" class="usa-link">1</a>E), indicating more severe motor deficits. Additionally, tyrosine hydroxylase (TH; key marker molecules of midbrain dopaminergic neurons) expression was significantly decreased in both WT and Gpr35<sup>−/−</sup> mice following MPTP injection (Fig. <a href="#F1" class="usa-link">1</a>F and G, SEM), consistent with selective dopaminergic neuron loss in the SN. However, the number of Nissl bodies (biomarkers of neuronal functional status) showed no significant changes in the Gpr35<sup>−/−</sup> mice (Fig. <a href="#F1" class="usa-link">1</a>F and H). Quantitative analysis revealed that MPTP administration significantly elevated midbrain neuronal apoptosis, as evidenced by increased NeuN<sup>+</sup>/caspase 3<sup>+</sup> double-positive cells. Importantly, Gpr35<sup>−/−</sup> PD mice exhibited substantially exacerbated apoptotic responses compared to WT PD controls (Fig. <a href="#F1" class="usa-link">1</a>F and I). Finally, we evaluated the inflammatory state. MPTP-induced PD mice displayed excessive microglial activation [ionized calcium binding adapter protein 1 (IBA1<sup>+</sup>), microglial activation markers] and elevated levels of the stress inflammatory enzymes inducible nitric oxide synthase (iNOS; inflammatory biomarkers). Notably, Gpr35<sup>−/−</sup> further exacerbated microglial activation and iNOS expression (Fig. <a href="#F1" class="usa-link">1</a>F, J, and K). Taken together, the data establish that genetic deletion of Gpr35 worsens key PD-related phenotypes in the MPTP model, particularly affecting motor performance, survival of dopaminergic neurons, and the progression of neuroinflammation.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/12376290/016c9c42e049/research.0846.fig.001.jpg" loading="lazy" height="660" width="630" alt="Fig. 1."></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Gpr35<sup>−/−</sup> exacerbates PD progression and inflammation in the SN. (A) Schematic diagram illustrating the generation of Gpr35<sup>−/−</sup> mice and the establishment of the PD model. (B) The average daily weight gain during the observation period was quantified (<em>n</em> = 10 biologically independent mice). (C) The total distance traveled in the open-field test was also quantified (<em>n</em> = 9 biologically independent mice). (D) The time mice spent crossing the central zone in the open-field test was recorded (<em>n</em> = 9 biologically independent mice). (E) Time required for mice to climb down from the top during the pole test (<em>n</em> = 9 biologically independent mice). (F) Representative fluorescence staining images of TH, Nissl bodies, Caspase 3<sup>+</sup> NeuN<sup>+</sup> cells, microglial marker IBA1, and iNOS in the SN (from top to bottom). Scale bars, 400 μm. (G to J) Quantitative analysis of fluorescence staining results showing the number of TH<sup>+</sup> cells (G), Nissl bodies (H), NeuN<sup>+</sup> Caspase 3<sup>+</sup> cells (I), and IBA1<sup>+</sup> cells (J), compared to the WT-NT group (<em>n</em> = 3 biologically independent mice). (K) Quantification of the mean fluorescence intensity of iNOS compared to the WT-NT group (<em>n</em> = 3 biologically independent mice). Data are presented as the mean ± SEM.</p></figcaption></figure></section><section id="sec4"><h3 class="pmc_sec_title">Gpr35<sup>−/−</sup> restructures gut microbial composition and metabolite profiles in WT and PD mouse models</h3>
<p>To elucidate the mechanism through which Gpr35 deletion exacerbates PD progression, we investigated its impact on gastrointestinal homeostasis, given its high expression in the gastrointestinal tract. We performed 16<em>S</em> ribosomal DNA identification analysis on 1,099 operational taxonomic units (OTUs). Microbial diversity analysis using the Shannon–Wiener index revealed comparable species-level distribution patterns among all 4 experimental groups (Fig. <a href="#supplementary-material-1" class="usa-link">S2</a>A). β-Diversity analysis revealed community composition difference through principal coordinate analysis (PCoA) and nonmetric multi-dimensional scaling (NMDS) (Fig. <a href="#F2" class="usa-link">2</a>A and Fig. <a href="#supplementary-material-1" class="usa-link">S2</a>B). <em>Parasutterella</em>, a genus associated with neurological disorders including schizophrenia and cerebral palsy [<a href="#B24" class="usa-link" aria-describedby="B24">24</a>,<a href="#B25" class="usa-link" aria-describedby="B25">25</a>], was highest in the GM group (Fig. <a href="#F2" class="usa-link">2</a>B). At the phylum level, <em>Bacteroidota</em> and <em>Firmicutes</em> predominated, while <em>Proteobacteria</em>, containing numerous pathogenic species, were most abundant in the GM group (Fig. <a href="#F2" class="usa-link">2</a>C). The Kruskal–Wallis test and linear discriminant analysis (LDA) both indicated that the relative abundance of <em>Lactobacillus</em> was significantly lower in Gpr35<sup>−/−</sup> mice than in WT controls, with an additional decline under PD conditions (Fig. <a href="#F2" class="usa-link">2</a>D and Fig. 2D, E, and G), highlighting its potential therapeutic implications in PD pathogenesis. In contrast to the WN and WM groups where <em>Akkermansia</em> and <em>Verrucomicrobiale</em>s were the predominant differential bacteria, Gpr35 knockout PD mice exhibited significantly elevated levels of <em>Clostridia</em> and <em>Lachnospirales</em> compared to normal Gpr35<sup>−/−</sup> mice in the GM group (Fig. <a href="#supplementary-material-1" class="usa-link">S2</a>J and K). Subsequently, we colonized <em>Lactobacillus</em> in the PD mouse model (Fig. <a href="#supplementary-material-1" class="usa-link">S1</a>E) and found that it could greatly alleviate motor dysfunction in the PD mice (Fig. <a href="#supplementary-material-1" class="usa-link">S1</a>F to K). Functional profiling of microbial communities was performed using PICRUSt2 (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States, version 2), which predicts metabolic potential from 16<em>S</em> ribosomal RNA (rRNA) gene sequences. At the third functional tier, significant changes in RNA transport, phenylalanine, tyrosine, and tryptophan biosynthesis were observed in WT mice before and after Gpr35<sup>−/−</sup> (Fig. <a href="#F2" class="usa-link">2</a>E).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/12376290/8ef52a59cabb/research.0846.fig.002.jpg" loading="lazy" height="611" width="660" alt="Fig. 2."></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Gpr35 ablation alters gut microbiota and metabolite composition in WT and PD mouse models. (A) β-Diversity of the gut microbiome from the cecal contents of WT and Gpr35<sup>−/−</sup> mice (<em>n</em> = 3 biologically independent mice) as determined by PCoA of Jaccard distances. (B and C) Average relative abundance of bacteria at the genus (B) and phylum (C) levels. (D) Screening results of differential microbial communities by Kruskal–Wallis test (<em><sup>*</sup>P</em> &lt; 0.05). (E) Significance analysis plots of differential functional pathways between WN versus GN groups (<sup>*</sup><em>P</em> &lt; 0.05 indicates a significant difference). (F and G) Heatmaps of differential metabolite clustering in positive (F) and negative (G) modes. The relative quantitative values of all differential metabolites were log<sub>10</sub>-transformed. Differential metabolites were screened based on the criteria of VIP &gt; 1.0, fold change (FC) &gt; 1.2 or FC &lt; 0.833, and <em>P</em> &lt; 0.05. WN, wild-type negative control mice; WM, wild-type MPTP-treated mice; GN, Gpr35<sup>−/−</sup> negative control mice; GM, Gpr35<sup>−/−</sup> MPTP-treated mice.</p></figcaption></figure><p>Untargeted metabolomic profiling identified lipids/lipid-like compounds and organic acids as predominant gut metabolites (Fig. <a href="#supplementary-material-1" class="usa-link">S2</a>C). KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway mapping demonstrated their primary involvement in 3 metabolic processes: amino acid metabolism (111 compounds), lipid metabolism (105 compounds), and digestive system regulation (62 compounds) (Fig. <a href="#supplementary-material-1" class="usa-link">S2</a>F). Variable importance in projection (VIP) analysis identified metabolomic signatures relevant to PD pathogenesis, showing marked intergroup differences. These included <span class="font-variant-small-caps">l</span>-aspartic acid (a neurotransmitter-related metabolite), docosahexaenoic acid (involved in lipid metabolism), trigonelline (associated with oxidative stress and inflammatory responses), jasmonic acid (a plant hormone with anti-inflammatory properties), <span class="font-variant-small-caps">d</span>-panthenol (related to mitochondrial energy metabolism), and Lysop 18:2 (implicated in sphingolipid metabolism pathways) (Fig. <a href="#F2" class="usa-link">2</a>F and G). It is noteworthy that KYNA levels were also significantly elevated following Gpr35 gene knockout. Functional annotation of differential metabolites between GN and WN groups through KEGG analysis revealed predominant associations with digestive processes, amino acid metabolic pathways, and membrane transport mechanisms (Fig. <a href="#supplementary-material-1" class="usa-link">S2</a>H). Metabolic pathway analysis identified significant enrichment in linoleic acid metabolism, specific amino acid pathways (including glutathione and arginine/proline metabolism), and adenosine triphosphate (ATP)-binding cassette (ABC) transporter systems (Fig. <a href="#supplementary-material-1" class="usa-link">S2</a>I). GSEA (gene set enrichment analysis) further demonstrated marked involvement of tyrosine/tryptophan metabolism (showing substantial enrichment in the GM group compared with WM) and neuroactive ligand–receptor interactions in both WT and Gpr35<sup>−/−</sup> PD models (Fig. <a href="#supplementary-material-1" class="usa-link">S3</a>A to C). The data presented in Fig. <a href="#supplementary-material-1" class="usa-link">S1</a> and Fig. <a href="#F2" class="usa-link">2</a>D and E collectively indicate that Gpr35 deletion decreases <em>Lactobacillus</em> abundance and perturbs tryptophan metabolism, suggesting its possible involvement in PD development via this metabolic pathway.</p>
<p>To elucidate the complex interplay between microbial communities and metabolism, we conducted an integrated analysis (Fig. <a href="#supplementary-material-1" class="usa-link">S3</a>D). The relative abundance of <em>Eubacterium_ventriosum</em> correlates with multiple metabolites. Analysis of WN versus WM groups revealed significant associations between <em>Rikenellaceae</em> and <em>Family_XIII_AD3011</em> abundance patterns and specific metabolic profiles.</p>
<p>Our findings include reduced <em>Lactobacillus</em> and increased <em>Proteobacteria</em> in Gpr35<sup>−/−</sup> mice, along with substantial alterations in metabolites related to neurotransmitters and lipid metabolism, along with relevant biochemical pathways including tyrosine metabolic processes and neuroactive ligand–receptor signaling cascades and tryptophan metabolism pathways. Integrated analysis reveals robust associations between particular microbial species and metabolic profiles, indicating that Gpr35 likely modulates PD progression via microbiota–metabolite crosstalk.</p></section><section id="sec5"><h3 class="pmc_sec_title">FMT treatment can reduce neuroinflammation and PD-related pathological changes in SN</h3>
<p>To further explore whether intestinal flora mediates the behavioral and phenotypic abnormalities observed in Gpr35<sup>−/−</sup> mice, as well as the potential role of gut flora in alleviating PD symptoms, we conducted fecal microbiota transplantation (FMT). The effect of bacterial colony removal is shown in Fig. <a href="#supplementary-material-1" class="usa-link">S4</a>. Figure <a href="#F3" class="usa-link">3</a>A outlines the experimental protocol for the FMT study. PD mice treated with negative control (NT) mouse microbiota showed significant weight recovery, while no significant weight gain was observed in PD mice treated with Gpr35<sup>−/−</sup> mouse microbiota (Fig. <a href="#F3" class="usa-link">3</a>B and Fig. <a href="#supplementary-material-1" class="usa-link">S1</a>D). Both FMT-treated groups showed behavioral improvements (Fig. <a href="#F3" class="usa-link">3</a>C to E and Fig. <a href="#supplementary-material-1" class="usa-link">S1</a>C). Histological analyses revealed that FMT treatment elevated counts of TH-immunoreactive neurons within the SN region (Fig. <a href="#F3" class="usa-link">3</a>F and G) and reduced neuronal apoptosis (Fig. <a href="#F3" class="usa-link">3</a>F and I). At the same time, there was no significant change in the number of Nissl bodies (Fig. <a href="#F3" class="usa-link">3</a>F and H). FMT also attenuated IBA1<sup>+</sup> microglial cells (Fig. <a href="#F3" class="usa-link">3</a>F and J) and reduced expression of iNOS (Fig. <a href="#F3" class="usa-link">3</a>F and K). Further analysis revealed that the therapeutic effects of microbiota from NT mice were more pronounced than those from Gpr35<sup>−/−</sup> mice. These findings indicate that intestinal microbiota substantially influences PD pathogenesis, with Gpr35-modulated microbial populations mediating improvements in both behavioral deficits and neuropathological features.</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/12376290/d0d6773e842a/research.0846.fig.003.jpg" loading="lazy" height="660" width="606" alt="Fig. 3."></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>FMT administration alleviates PD-associated histological alterations and inflammation in the SN. (A) Schematic representation of the FMT procedure. (B) The average daily weight gain during this period was quantified (<em>n</em> = 8 biologically independent mice). (C and D) Quantitative analysis of open-field test results: Time spent crossing the central zone (D) and total distance traveled (C) were recorded (<em>n</em> = 8 biologically independent mice). (E) Time required for mice to climb down from the top in the pole test (<em>n</em> = 8 biologically independent mice). (F) Representative fluorescence staining images of TH, Nissl bodies, NeuN<sup>+</sup> Caspase 3<sup>+</sup> cells, microglial marker IBA1, and iNOS in the SN (top to bottom). Scale bars, 400 μm. (G to J) Quantitative analysis of fluorescence staining results: The number of TH<sup>+</sup> cells (G), Nissl bodies (H), NeuN<sup>+</sup> Caspase 3<sup>+</sup> cells (I), and IBA1<sup>+</sup> cells (J) was calculated (<em>n</em> = 3 biologically independent mice). (K) Quantification of mean fluorescence intensity of iNOS, normalized to the NT group (<em>n</em> = 3 biologically independent mice). Data are presented as mean ± SEM.</p></figcaption></figure></section><section id="sec6"><h3 class="pmc_sec_title">Gpr35 regulates intestinal structure and barrier integrity in both MPTP-induced and FMT-treated mouse models</h3>
<p>We have demonstrated that Gpr35<sup>−/−</sup> exacerbated PD progression and inflammation, and this effect was mediated by alterations in intestinal flora. Considering the predominant expression of Gpr35 in the gut epithelium, we further explored the effects of Gpr35<sup>−/−</sup> on the gut. In WT-MPTP mice, colitis-like pathological features were observed, including an increased villus-to-crypt length ratio (Fig. <a href="#F4" class="usa-link">4</a>B), abnormal morphology of intestinal mucosal crypts, and edema, although no inflammatory cell infiltration was detected compared to WT-NT mice (Fig. <a href="#F4" class="usa-link">4</a>A, top). In Gpr35<sup>−/−</sup>-MPTP mice, the villus-to-crypt length ratio was significantly elevated (Fig. <a href="#F4" class="usa-link">4</a>B), alongside inflammatory cell infiltration and abnormal crypt architecture in the intestinal mucosa compared to Gpr35<sup>−/−</sup>-NT mice (Fig. <a href="#F4" class="usa-link">4</a>A, top). FMT experiments further demonstrated that microbiota from WT mice alleviated edema and inflammatory cell infiltration in PD mice. However, PD mice receiving microbiota from Gpr35<sup>−/−</sup> mice continued to exhibit intestinal edema and inflammatory cell infiltration (Fig. <a href="#F4" class="usa-link">4</a>F, top). We also analyzed intestinal barrier integrity by staining for Claudin 5. Claudin 5 expression was reduced in both WT-MPTP and Gpr35<sup>−/−</sup>-MPTP mice after MPTP induction (Fig. <a href="#F4" class="usa-link">4</a>A, bottom, and C). However, Gpr35<sup>−/−</sup>-MPTP mice exhibited more severe barrier integrity damage compared to WT-MPTP mice (Fig. <a href="#F4" class="usa-link">4</a>A, bottom, and C). In FMT-treated mice, intestinal barrier integrity was restored to varying degrees by flora from both WT and Gpr35<sup>−/−</sup> mice, with WT flora demonstrating significantly better restorative effects (Fig. <a href="#F4" class="usa-link">4</a>F, bottom, and E). Notably, in the FMT experiments, microbiota transplantation from either WT or Gpr35<sup>−/−</sup> mice failed to restore the villus/crypt ratio, demonstrating that while FMT could not reverse PD-induced structural alterations in intestinal morphology, it effectively ameliorated both intestinal inflammation and barrier integrity impairment caused by PD. In conclusion, Gpr35 stabilizes intestinal structure and barrier integrity in both MPTP-induced and FMT-treated mouse models, further underscoring the connection between Gpr35, gut flora, and PD pathology.</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/12376290/47c62589c298/research.0846.fig.004.jpg" loading="lazy" height="563" width="660" alt="Fig. 4."></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Effects of Gpr35 on intestinal structure and barrier integrity in PD mice. (A and F) Representative images of hematoxylin and eosin (H&amp;E) staining (top) and fluorescence staining of Claudin 5 (bottom) in the colon. (B and D) Quantitative analysis of villus length and crypt depth (<em>n</em> = 5 biologically independent mice). (C and E) Quantification of Claudin 5 fluorescence intensity (<em>n</em> = 3 biologically independent mice).</p></figcaption></figure></section><section id="sec7"><h3 class="pmc_sec_title">Gpr35 agonist KYNA inhibits neuronal apoptosis and microglial inflammatory responses</h3>
<p>To explore the effect of Gpr35 expression on PD in brain, we established an in vitro neuroinflammation model by stimulating BV-2 microglial cells with lipopolysaccharide (LPS) and an in vitro neuronal apoptosis model by treating SN4741 dopaminergic neurons with 1-methyl-4-phenylpyridiniumion (MPP<sup>+</sup>). The potential cytotoxic effects of KYNA on BV-2 microglia were evaluated through the Cell Counting Kit-8 (CCK-8) assay. Results indicated that 50 μM KYNA significantly enhanced microglial cell viability, whereas 1,000 μM KYNA significantly inhibited cell activity (Fig. <a href="#F5" class="usa-link">5</a>A). Additionally, KYNA significantly inhibited the release of inflammatory cytokines induced by LPS (Fig. <a href="#F5" class="usa-link">5</a>B to D). As a critical regulator of inflammatory responses, nuclear factor κB (NF-κB) functions as a key transcriptional modulator. After KYNA treatment, p65 was primarily found in the cytoplasm, thereby partially terminating the signaling of pro-inflammatory factors (Fig. <a href="#F5" class="usa-link">5</a>E). At the protein level, KYNA was observed to significantly inhibit the expression of cyclooxygenase-2 (COX-2) and iNOS. Further, it promoted the expression of the anti-inflammatory protein Arginase-1 (Arg-1; Fig. <a href="#F5" class="usa-link">5</a>E to G and Fig. <a href="#supplementary-material-1" class="usa-link">S5</a>E to G). Given that oxidative stress can exacerbate inflammatory responses and contribute to neurodegenerative and metabolic diseases, the total antioxidant capacity, nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide (reduced form) (NAD<sup>+</sup>/NADH) ratio, and levels of glutathione (GSH), catalase (CAT), and superoxide dismutase (SOD) in BV-2 cells were measured. Results showed that LPS treatment reduced the oxidation resistance of BV-2 cells, an effect that was effectively reversed by KYNA treatment (Fig. <a href="#F5" class="usa-link">5</a>H to J and Fig. <a href="#supplementary-material-1" class="usa-link">S5</a>C and D). Additionally, KYNA efficiently cleared the accumulation of harmful oxidative products, such as reactive oxygen species (ROS) and malondialdehyde (MDA), which are induced by inflammation (Fig. <a href="#F5" class="usa-link">5</a>K and L). Transmission electron microscopy (TEM) revealed that LPS-treated BV-2 cells exhibited marked mitochondrial damage compared to the control group, characterized by sparse and fragmented mitochondrial cristae. Some mitochondria changed from a normal oval shape to a swollen, rounded morphology, suggesting mitochondrial permeability transition and outer membrane rupture. However, KYNA treatment partially restored these abnormal mitochondrial morphologies (Fig. <a href="#F5" class="usa-link">5</a>M). JC-1 staining further confirmed that KYNA effectively alleviated the LPS-induced decline in mitochondrial membrane potential (Fig. <a href="#supplementary-material-1" class="usa-link">S5</a>A and B). Collectively, these results indicate that KYNA, acting as a putative Gpr35 agonist, regulates inflammatory responses and reduces oxidative stress, effectively mitigating mitochondrial structural impairment and membrane potential decline. By maintaining mitochondrial integrity in BV-2 cells, KYNA may contribute to slowing PD progression.</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/12376290/6ba5495e3795/research.0846.fig.005.jpg" loading="lazy" height="660" width="407" alt="Fig. 5."></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Modulation of microglial activation and neuroprotective effects by Gpr35 agonist KYNA in murine cellular models. (A) Concentration-dependent effects of KYNA (5 to 1,000 μM) on BV-2 microglial cell viability assessed by CCK-8 assay. (B to D) KYNA-mediated suppression of proinflammatory cytokine secretion in BV-2 cells quantified by enzyme-linked immunosorbent assay (ELISA): interleukin-1β (IL-1β; B), interleukin-6 (IL-6; C), and tumor necrosis factor-α (TNF-α; D). (E) Immunofluorescence visualization of polarization markers in BV-2 cells: iNOS, M1 marker (upper panel); Arg-1, M2 marker (middle panel); and NF-κB p65 subunit translocation (lower panel). Scale bar, 20 μm. (F and G) Semiquantitative analysis of iNOS (F) and Arg-1 (G) fluorescence intensity normalized to 4′,6-diamidino-2-phenylindole (DAPI) nuclear staining. (H to L) Comprehensive evaluation of KYNA’s antioxidant effects in BV-2 cells. (H) CAT enzymatic activity. (I) Total antioxidant capacity assessed by ferric reducing antioxidant power (FRAP) assay. (J) SOD activity. (K) MDA content reflecting lipid peroxidation. (L) Intracellular ROS levels detected by dichloro-dihydro-fluorescein diacetate (DCFH-DA) fluorescence. (M) Ultrastructural analysis of mitochondrial integrity by TEM. Yellow arrowheads indicate cristae morphology. Scale bar, 500 nm. Data represent mean ± SEM from ≥3 biological replicates. Statistical significance was determined by one-way ANOVA with Tukey’s post hoc test.</p></figcaption></figure></section><section id="sec8"><h3 class="pmc_sec_title">KYNA reprograms multi-omics profiles in BV-2 microglia</h3>
<p>To elucidate molecular-level alterations and their regulatory mechanisms, we performed integrated transcriptomic and proteomic profiling of microglia treated with Gpr35 agonists. Comparative analysis across experimental groups quantified differentially expressed genes (DEGs) and proteins (DEPs).</p>
<p>KEGG annotation revealed that DEGs between LPS-treated and KYNA + LPS-treated groups were predominantly associated with neurodegenerative diseases, signal transduction cascades, and immune system regulation (Fig. <a href="#F6" class="usa-link">6</a>A). Functional enrichment analysis revealed marked associations of the DEGs with major neurodegenerative disorders [PD, Huntington’s disease, and Alzheimer’s disease (AD)], potentially mediated through impaired oxidative phosphorylation and aberrant tumor necrosis factor (TNF) signaling. These findings were corroborated by parallel protein functional annotation results (Fig. <a href="#F6" class="usa-link">6</a>B and D).</p>
<figure class="fig xbox font-sm" id="F6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/12376290/dc19ec11d9e2/research.0846.fig.006.jpg" loading="lazy" height="660" width="564" alt="Fig. 6."></p>
<div class="p text-right font-secondary"><a href="figure/F6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Transcriptomic and proteomic profiling of BV-2 cells in response to Gpr35 agonist KYNA treatment. (A) KEGG functional annotation of DEGs between the LPS-treated and KYNA + LPS-treated groups. (B) KEGG pathway enrichment analysis of DEGs, highlighting functional differences between the LPS and KYNA + LPS groups. (C) KEGG pathway enrichment analysis of DEPs, highlighting functional differences between the LPS and KYNA + LPS groups. (D) Functional classification histogram of proteins based on EggNOG database. (E) Expression levels of representative DEPs (raw intensity values) between LPS and KYNA + LPS groups. Differential proteins were identified based on FC criteria (FC &gt; 1.2 or FC &lt; 0.833 with <em>P</em> &lt; 0.05), but raw expression intensities are displayed to visualize absolute abundance changes. Data are presented as mean ± SEM; <em><sup>*</sup>P</em> &lt; 0.05, <em><sup>**</sup>P</em> &lt; 0.01.</p></figcaption></figure><p>Parallel proteomic quantification identified marked DEPs across experimental groups (Fig. <a href="#supplementary-material-1" class="usa-link">S6</a>C and D). The Subloc annotation demonstrates the spatial localization of these proteins (Fig. <a href="#supplementary-material-1" class="usa-link">S6</a>E), with the functional annotation highlighting their roles in metabolic reprogramming and neurodegenerative disease-related pathways (Fig. <a href="#F6" class="usa-link">6</a>D). KEGG enrichment analysis of DEPs between the 2 groups found that these markedly different proteins are primarily associated with the mTOR (mammalian target of rapamycin) signaling pathway, cellular senescence regulation, and IL-17 and p53 signaling pathway (Fig. <a href="#F6" class="usa-link">6</a>C). Subcellular localization localized these DEPs primarily to the cytoplasm, nucleus, and mitochondria (Fig. <a href="#supplementary-material-1" class="usa-link">S6</a>F).</p>
<p>LPS treatment was found to significantly down-regulate mitochondrial outer membrane transport proteins, including the outer mitochondrial membrane 40 (TOM40) and heat shock protein A9 (HSPA9), as well as NADH dehydrogenase 4 (MT-ND4), a critical subunit of mitochondrial respiratory chain complex I. Additionally, LPS activated several key signaling molecules: calcium/calmodulin-dependent protein kinase 1 (CAMK1), which is associated with calcium channel regulation; ubiquitin-conjugating enzyme E2D4 (UBE2O), an E2 ubiquitin-conjugating enzyme implicated in apoptosis; protein phosphatase 4 catalytic subunit (PPP4C), a phosphatase involved in cell cycle progression; and cancer-related proteins deleted in liver cancer 2 (DLC2) and tensin-3 (Fig. <a href="#F6" class="usa-link">6</a>E). Importantly, administration of KYNA effectively reversed these LPS-induced alterations, restoring mitochondrial transport protein expression levels and attenuating pro-apoptotic signaling pathways. This suggests that activation of Gpr35 alleviates inflammation-mediated mitochondrial dysfunction and associated cellular stress.</p></section><section id="sec9"><h3 class="pmc_sec_title">Gpr35 small interfering RNA knockdown reverses KYNA-mediated anti-inflammatory, antioxidant, and neuroprotective effects</h3>
<p>To further investigate whether Gpr35 is a key protein mediating KYNA regulation of inflammation, oxidative stress, and apoptosis, we constructed small interfering RNA (siRNA) targeting Gpr35. To identify the most effective siRNA candidate, we evaluated the silencing efficiency of 3 Gpr35-targeting siRNAs (provided by Genema Biotech) in both BV-2 and SN4741 cell lines using reverse transcription quantitative polymerase chain reaction (RT-qPCR) analysis. As demonstrated in Fig. <a href="#supplementary-material-1" class="usa-link">S7</a>, siRNA-3 exhibited significantly superior knockdown efficiency compared to the other 2 candidates. Our results demonstrated that KYNA promotes M2 polarization (alternative activation) while inhibiting M1 polarization (classical activation) in BV-2 microglial cells. However, when cells were treated with siRNA targeting Gpr35, the effects of KYNA were significantly reversed (Fig. <a href="#F7" class="usa-link">7</a>E to I and Fig. <a href="#supplementary-material-1" class="usa-link">S8</a>D to K).</p>
<figure class="fig xbox font-sm" id="F7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/12376290/061cbed72eb7/research.0846.fig.007.jpg" loading="lazy" height="660" width="604" alt="Fig. 7."></p>
<div class="p text-right font-secondary"><a href="figure/F7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Impact of Gpr35 siRNA knockdown on BV-2 and SN4741 cells. (A) Representative immunofluorescence images showing the expression of iNOS (left), Arg-1 (middle), and NF-κB p65 (right) in BV-2 microglial cells with or without Gpr35 siRNA knockdown. (B and C) Quantification of relative fluorescence intensity for iNOS (B) and Arg-1 (C) from immunofluorescence staining. (D) Wright’s staining of SN4741 cells following MPP<sup>+</sup> stimulation and treatment under different conditions. (E to J) RNA expression of inflammatory cytokines (<em>IL-1β</em>, <em>TNF-α</em>, <em>CCL1</em>, <em>Arg-1</em>, <em>IL-10</em>, and <em>CAT</em>) in BV-2 microglial cells. (K to N) Analysis of oxidative stress markers in BV-2 cells: total antioxidant capacity measured by the FRAP assay (K), GSH levels (L), total SOD concentration (M), and MDA levels (N). Data are pooled from at least 2 independent experiments and presented as mean ± SEM.</p></figcaption></figure><p>Additionally, siRNA treatment reversed the regulatory effects of KYNA on cellular antioxidant capacity [<em>glutamate-cysteine ligase catalytic subunit</em> (<em>GCLC</em>), g<em>lutamate-cysteine ligase modifier subunit</em> (<em>GCLM</em>) (Fig. <a href="#supplementary-material-1" class="usa-link">S8</a>L and M), and <em>CAT</em> (Fig. <a href="#F7" class="usa-link">7</a>J)] and also reversed the expression of GSH and SOD (Fig. <a href="#F7" class="usa-link">7</a>L and M). Consequently, harmful oxidative species accumulated excessively within the cells (Fig. <a href="#supplementary-material-1" class="usa-link">S6</a>N). In the neuronal apoptosis model, The CCK-8 viability analysis indicated that MPP<sup>+</sup> induced a concentration-dependent inhibition of cell viability (Fig. <a href="#supplementary-material-1" class="usa-link">S5</a>H), which was also confirmed by the lactate dehydrogenase (LDH) assay results (Fig. <a href="#supplementary-material-1" class="usa-link">S5</a>I). Meanwhile, the siRNA diminished the protective effects of KYNA on SN4741 cell viability (Fig. <a href="#supplementary-material-1" class="usa-link">S5</a>K). Similarly, in the coculture system of BV-2 and SN4741 cells, siRNA inhibited the protective effects of KYNA on SN4741 cells (Fig. <a href="#supplementary-material-1" class="usa-link">S5</a>J), as confirmed by fluorescence staining of the apoptotic marker Caspase 3 (Fig. <a href="#supplementary-material-1" class="usa-link">S8</a>B and C). Furthermore, Wright and Nissl staining showed that KYNA improved the morphological changes induced by MPP<sup>+</sup> in neurons, such as reduced synaptic density, rounding of the cell body, and a marked decrease in cell density. However, siRNA treatment reversed these effects (Fig. <a href="#F7" class="usa-link">7</a>D and Fig. <a href="#supplementary-material-1" class="usa-link">S8</a>A).</p>
<p>In summary, while siRNA-mediated reversal of KYNA’s effects suggests Gpr35 as a potential regulatory target, the absence of negative controls in the experiments warrants cautious interpretation of these findings. In conclusion, Gpr35 not only delays PD progression by modulating gut microbiota and metabolites but also directly regulates PD pathogenesis in the nervous system by controlling inflammation, oxidative stress, and neuronal apoptosis.</p></section></section><section id="sec10"><h2 class="pmc_sec_title">Discussion</h2>
<p>The course and development of PD are related to neuroinflammation, intestinal microbial disorders, neuronal apoptosis, and oxidative stress [<a href="#B26" class="usa-link" aria-describedby="B26">26</a>]. Studies indicate that microglia in the SN of PD patients are chronically activated, leading to increased levels of neuroinflammatio [<a href="#B27" class="usa-link" aria-describedby="B27">27</a>]. Under inflammatory conditions, activated microglia release pro-inflammatory mediators, leading to dopaminergic neuron damage [<a href="#B28" class="usa-link" aria-describedby="B28">28</a>]. Mounting evidence underscores the pivotal involvement of intestinal microbial communities and their metabolic byproducts in PD pathogenesis [<a href="#B8" class="usa-link" aria-describedby="B8">8</a>,<a href="#B9" class="usa-link" aria-describedby="B9">9</a>]. It is worth noting that previous studies failed to identify therapeutic or intervention targets in line with the functional principle of gut–brain association.</p>
<p>Gpr35 has been reported to be capable of regulating intestinal barrier integrity and brain neuroplasticity [<a href="#B29" class="usa-link" aria-describedby="B29">29</a>,<a href="#B30" class="usa-link" aria-describedby="B30">30</a>], but it failed to be unveiled as the essential role in bridging the gut and brain association or neurodegenerative symptoms. Our investigation provides novel insights into Gpr35’s neuroprotective function in PD, revealing that genetic ablation of Gpr35 aggravates disease pathology through enhanced motor deficits, accelerated dopaminergic neuron degeneration, and amplified neuroinflammatory responses in PD mouse models. Through FMT and multi-omics analysis, we reveal that Gpr35 modulates PD pathogenesis by regulating the gut microbiota, particularly lactic acid bacteria, and metabolites related to neurotransmitters and lipid metabolism. Furthermore, the Gpr35 agonist KYNA exhibits marked neuroprotective, anti-inflammatory, and antioxidant effects in vitro, while siRNA targeting Gpr35 suppresses these effects, as demonstrated using microglia and neuron cell models. Integrated gut–brain evidence suggests that Gpr35 may function through a “dual gut–brain mechanism”, which explains the therapeutic effects observed with both FMT and KYNA treatment.</p>
<p>This research conducted a systematic exploration of Gpr35’s impact on PD progression, focusing specifically on its relationship with intestinal microbial communities and associated metabolic products. Our findings revealed that Gpr35 deficiency resulted in a reduction of <em>Lactobacillus</em> populations within the gut microbiome, a phenomenon that becomes more pronounced during PD progression. Contemporary scientific literature emphasizes the crucial involvement of intestinal flora and their metabolic byproducts in PD pathogenesis [<a href="#B31" class="usa-link" aria-describedby="B31">31</a>,<a href="#B32" class="usa-link" aria-describedby="B32">32</a>]. This might be attributed to 2 main factors: First, PD can lead to intestinal disease due to autonomic dysfunction [<a href="#B33" class="usa-link" aria-describedby="B33">33</a>]; additionally, alterations in microbial composition and metabolite profiles directly affect neuroinflammatory processes underlying disease progression [<a href="#B34" class="usa-link" aria-describedby="B34">34</a>]. For instance, <em>Prevotella</em> and <em>Lactobacillus</em> are significantly reduced in PD patients [<a href="#B35" class="usa-link" aria-describedby="B35">35</a>]. Probiotic supplementation, particularly with <em>Lactobacillus</em>, has been shown to alleviate constipation and potentially improve motor symptoms by modulating gut microbiota [<a href="#B36" class="usa-link" aria-describedby="B36">36</a>]. Clinical evidence confirms that multi-strain probiotic formulations containing <em>Lactobacillus</em> enhance intestinal motility and reduce transit time in PD patients with constipation [<a href="#B37" class="usa-link" aria-describedby="B37">37</a>], findings that align with our study. Multi-omics analyses and colonization experiments identify <em>Lactobacillus</em> as a key microbiota mediator of Gpr35’s regulatory effects in PD, although future validation using genetically engineered strains is required to establish causality.</p>
<p>Gut microbiota regulation of host physiology is closely linked to intestinal metabolites [<a href="#B38" class="usa-link" aria-describedby="B38">38</a>]. In WT and Gpr35<sup>−/−</sup> PD mice, our analysis revealed marked enrichment in several neural signaling pathways, including neuroactive ligand–receptor interactions, along with tyrosine and tryptophan metabolic processes. The enzymatic activity of aromatic amino acid aminotransferase (ArAT) and indole lactate dehydrogenase (ILDH) enables <em>Lactobacillus</em> strains to metabolize tryptophan into indole derivatives including indolyl aldehyde and indolyl lactic acid [<a href="#B39" class="usa-link" aria-describedby="B39">39</a>]. These metabolites activate aromatic receptors (AHRs), which regulate intestinal immune barrier function [<a href="#B40" class="usa-link" aria-describedby="B40">40</a>], suppress inflammation, and enhance gut barrier integrity. <em>Lactobacillus</em> may also regulate tyrosine metabolism [<a href="#B41" class="usa-link" aria-describedby="B41">41</a>], influencing neurotransmitters like dopamine and norepinephrine, which affect neurobehavior via the gut–brain axis [<a href="#B42" class="usa-link" aria-describedby="B42">42</a>]. Additionally, vitamin B2, KYNA, and trigonelline, which are related to these metabolic pathways [<a href="#B43" class="usa-link" aria-describedby="B43">43</a>–<a href="#B45" class="usa-link" aria-describedby="B45">45</a>], were also enriched in our study. The accumulation of KYNA following Gpr35 gene knockout may reflects a compensatory elevation of ligand levels in response to impaired receptor signaling, which deserves further research in the future. While our metabolomics analysis revealed marked alterations in tryptophan/tyrosine metabolic pathways, the functional implications remain to be validated through in vitro isotope tracing or in vivo metabolic flux analysis. Future studies employing stable isotope labeling (e.g., <sup>13</sup>C-tryptophan) or mono-colonization models will elucidate the direct effects of <em>Lactobacillus</em>-derived metabolites on neuroinflammation.</p>
<p>For examination of Gpr35’s contribution to PD mechanisms within the brain, we explored the cerebral environment in PD mice. Literature indicates that PD progression exacerbates neuroinflammation, oxidative stress, and neuronal apoptosis in the affected regions [<a href="#B46" class="usa-link" aria-describedby="B46">46</a>]. KYNA has been found in some studies that exerts anti-inflammatory effects via the Gpr35 protein in neuroinflammation and pneumonia [<a href="#B23" class="usa-link" aria-describedby="B23">23</a>,<a href="#B47" class="usa-link" aria-describedby="B47">47</a>]. KYNA also significantly up-regulates antioxidant enzyme expression in the ovine ventricle [<a href="#B48" class="usa-link" aria-describedby="B48">48</a>]. Furthermore, KYNA specifically inhibits NLRP3 inflammasome activation through Gpr35, thereby preventing Caspase 1 cleavage [<a href="#B49" class="usa-link" aria-describedby="B49">49</a>]. In our study, we found that activating Gpr35 inhibits BV-2 cell activation by suppressing NF-κB p65 nuclear translocation and promotes M2 polarization. This activation also enhances the antioxidant capacity of BV-2 cells. In SN4741 cells, Gpr35 activation effectively inhibits neuronal apoptosis by suppressing Caspase 3 expression. Our study found that targeting Gpr35 can effectively regulate PD.</p>
<p>Although the final validation experiments lacked scramble controls, we had previously confirmed that siRNA-3 achieved significantly higher knockdown efficiency than negative controls (NC) during preliminary screening. Moreover, this specific sequence has been functionally validated in prior studies [<a href="#B50" class="usa-link" aria-describedby="B50">50</a>,<a href="#B51" class="usa-link" aria-describedby="B51">51</a>]. While these siRNA results should be considered preliminary evidence, we plan to further verify target specificity by generating Gpr35 conditional knockout cell lines or employing CRISPR-based approaches in future investigations. Our study acknowledges certain limitations in experimental modeling and mechanistic exploration. The MPTP-induced PD model primarily mimics acute neurotoxicity rather than the chronic, multifactorial nature of human PD, and it fails to replicate α-syn aggregation [<a href="#B52" class="usa-link" aria-describedby="B52">52</a>]. Furthermore, the current model demonstrates limitations in replicating nonmotor symptoms [<a href="#B35" class="usa-link" aria-describedby="B35">35</a>], which represents an area requiring further refinement in future investigations, This may lead to an incomplete understanding of PD pathogenesis and affect the study of Gpr35 mechanisms. Nevertheless, MPTP exhibits selective neurotoxicity specifically targeting the nigrostriatal dopaminergic pathway, which closely recapitulates the cardinal pathological hallmark of PD while demonstrating minimal effects on other neuronal populations, coupled with its advantages of producing limited systemic toxicity in animals and high experimental reproducibility [<a href="#B53" class="usa-link" aria-describedby="B53">53</a>], thereby establishing it as an indispensable tool for PD research. The current study did not employ conditional knockout models (e.g., Villin-Cre or Cx3cr1-Cre), thus precluding definitive discrimination between Gpr35’s independent roles in intestinal epithelial versus microglial cells. All references to “dual mechanisms” or “gut–CNS bidirectional regulation” in this work should be interpreted as speculative hypotheses rather than causal conclusions. Future investigations utilizing cell type-specific knockout models will be required for definitive validation. For instance, downstream pathways of Gpr35 in regulating gut microbiota and neuroinflammation are not fully defined, and KYNA’s impact on signaling pathways like NF-κB requires further validation. Beyond the 2 Gpr35-mediated regulatory pathways in PD pathogenesis elucidated in this study, its well-documented role in peripheral immune modulation may represent an additional mechanistic pathway influencing PD progression, which warrants systematic investigation in future research [<a href="#B19" class="usa-link" aria-describedby="B19">19</a>,<a href="#B54" class="usa-link" aria-describedby="B54">54</a>]. Additionally, KYNA, as a Gpr35 agonist, may interact with other receptors such as N-methyl-D-aspartate receptor (NMDAR) [<a href="#B55" class="usa-link" aria-describedby="B55">55</a>], and whether its anti-inflammatory effects in vitro fully depend on Gpr35 needs to be verified with more specific tools.</p>
<p>To address these limitations, future research should employ organoid models and clinical trial data that better mimic human characteristics. Human-derived gut–brain axis organoid models could simulate how microbial metabolites (e.g., KYNA) affect neuroinflammation via Gpr35. Furthermore, as an endogenous agonist of Gpr35, KYNA has been systematically evaluated in cognitive disorders through a comprehensive review and meta-analysis [<a href="#B56" class="usa-link" aria-describedby="B56">56</a>]. Future clinical drug development for PD should rigorously assess the blood–brain barrier permeability and chronic toxicity profiles of KYNA analogs. We propose implementing combination strategies, such as co-administration of KYNA with <em>Lactobacillus</em>, to enhance therapeutic efficacy and facilitate clinical translation. Integrating multi-omics data analysis may also offer a more comprehensive view of PD pathogenesis and help establish the brain–gut–metabolism regulatory axis through potential correlations among multiple indicators.</p></section><section id="sec11"><h2 class="pmc_sec_title">Conclusion</h2>
<p>As shown in Figure <a href="#F8" class="usa-link">8</a>, this study systematically explored the role of Gpr35 in PD and its regulatory mechanisms. This study systematically explored the role of Gpr35 in PD and its regulatory mechanisms. Gpr35 deficiency was found to exacerbate motor dysfunction, dopaminergic neurodegeneration, and neuroinflammation in PD models, while activation of Gpr35 by the agonist KYNA demonstrated substantial neuroprotective and anti-inflammatory effects. Additionally, Gpr35 modulates PD pathology by influencing gut microbiota composition (particularly <em>Lactobacillus</em>) and metabolic pathways such as tryptophan and tyrosine metabolism. These findings preliminarily suggest that Gpr35 may participate in PD progression through dual pathways involving gut microbiota and neuroinflammation, providing a theoretical foundation for subsequent mechanistic investigations. However, the causal relationships require further validation through cell-specific models and functional microbiota studies.</p>
<figure class="fig xbox font-sm" id="F8"><h3 class="obj_head">Fig. 8.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b048/12376290/0cfd000a11d8/research.0846.fig.008.jpg" loading="lazy" height="466" width="660" alt="Fig. 8."></p>
<div class="p text-right font-secondary"><a href="figure/F8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic summary of the study. Gpr35 signaling attenuates neuroinflammation, promotes enrichment of gut Lactobacillus, and ameliorates motor deficits in the MPTP mouse model of PD.</p></figcaption></figure></section><section id="sec12"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="sec13"><h3 class="pmc_sec_title">Chemicals and reagents</h3>
<p>This section is presented in Table S1.</p></section><section id="sec14"><h3 class="pmc_sec_title">Mice</h3>
<p>All experimental protocols involving animals were carried out in compliance with ethical standards for laboratory animal welfare, with official authorization granted by the Institutional Animal Care and Use Committee at Jilin University (authorization code: SY202411002).</p>
<p>Male C57BL/6J mice (specific pathogen-free, aged 8 weeks) were acquired from Benxi-based Changsheng Biotechnology Co. Ltd. (China). Gpr35-deficient mice (model number: NM-KO-2106644) were sourced from Shanghai Model Organisms Center Inc. (Shanghai, China). The animals were housed in standard laboratory facilities maintained under controlled environmental conditions. These facilities operated on a 12-h photoperiod cycle with ambient temperature regulation at 22 ± 2 °C. Throughout the study period, all subjects received unrestricted nutritional provisions and hydration access.</p>
<p>For the animal experiments, while key assays (immunofluorescence quantification and RT-qPCR) were performed with a sample size of <em>n</em> = 3—meeting the minimum requirements for preliminary exploratory studies—this limited scale was constrained by available resources and time constraints. Consequently, these histological and molecular data should be interpreted as supportive evidence, with primary conclusions drawn from the larger-scale behavioral tests (<em>n</em> = 8 to 10). Future replication studies with expanded sample sizes are warranted to validate these findings.</p></section><section id="sec15"><h3 class="pmc_sec_title">Subacute MPTP model induction and FMT administration</h3>
<p>After adaptation for 1 week, the mice were induced with a PD model via a subacute method as previously described [<a href="#B52" class="usa-link" aria-describedby="B52">52</a>]. The experimental protocol involved administering daily intraperitoneal doses of MPTP [99.54% purity, dissolved in phosphate-buffered saline (PBS)] at 30 mg/kg/day over 7 consecutive days. Model validation assessments were conducted 7 d after completing the treatment regimen.</p>
<p>For FMT experiments, the intrinsic microbiota of the mice was cleared by administering an antibiotic solution consisting of penicillin (1 g/l), metronidazole (1 g/l), neomycin (1 g/l), and vancomycin (0.5 g/l) in their drinking water over a 14-d period. During the first week, antibiotics were also administered orally (penicillin, 200 mg/kg; metronidazole, 200 mg/kg; neomycin, 200 mg/kg; vancomycin, 100 mg/kg). For the subsequent week, only antibiotic-containing drinking water was provided to the mice to maintain microbiota depletion. In this period, we also monitored the weight changes and water intake. Fresh feces were collected from control and Gpr35<sup>−/−</sup> mice, and we placed them in a sterile container, with 600 mg of samples rapidly homogenized in 6 ml of saline for 60 s. This mixture underwent filtration through sterile mesh to eliminate particulate matter before centrifugation at 1,000<em>g</em> (4 °C) for 3 min. The resulting supernatant was used for oral inoculation of recipient mice within 10 min using gastric gavage. Post-transplantation monitoring included fecal sample collection within 7 d for microbial analysis through either 16<em>S</em> rRNA sequencing or bacterial culture techniques. We aliquoted the unused fecal suspension and added 20% sterile glycerol before storing it at −80 °C in an ultra-low temperature freezer. The storage duration was limited to no more than 6 months to ensure sample integrity.</p></section><section id="sec16"><h3 class="pmc_sec_title">
<em>Lactobacillus</em> colonization</h3>
<p>We revived the cryopreserved <em>Lactobacillus</em> strains by selecting a small number of colonies and inoculating them into Man Rogosa Sharpe broth (MRS) liquid medium. Cultivation occurred under static conditions at 37 °C for 18 to 24 h, with periodic optical density measurements tracking microbial proliferation. Once turbidity was evident, we harvested a small aliquot of the culture for Gram staining and microscopic examination to confirm the morphological integrity and purity of the <em>Lactobacillus</em> strains. Subsequent bacterial separation involved centrifugation at 4,000<em>g</em> for 10 min, followed by triple washing cycles using physiological saline to eliminate medium residues. The cellular precipitate was reconstituted in sterile saline solution, with viable counts quantified through serial dilution plating techniques. Daily oral administration of bacterial suspensions (10<sup>7</sup> to 10<sup>9</sup> viable units per animal) continued for 3 weeks. MPTP-induced Parkinsonian models were established through intraperitoneal neurotoxin injection on day 14 of the regimen. One week after PD induction, we evaluated the effects of <em>Lactobacillus</em> on PD mice through a series of behavioral experiments.</p></section><section id="sec17"><h3 class="pmc_sec_title">Behavioral test</h3>
<p>Behavioral experiments were conducted 1 week after the completion of drug administration.</p>
<p>For the open-field experiment [<a href="#B57" class="usa-link" aria-describedby="B57">57</a>], a rectangular enclosure with 25- to 30-cm wall height and quadrilateral floor dimensions of 72 cm per side was employed. Black paint was applied to the interior surfaces to maintain consistent visual contrast. A digital camera was mounted 2 m above the apparatus to ensure complete and clear coverage of the entire open field. The test was conducted in a quiet, well-lit room to minimize external disturbances. We placed each mouse in the center of the box and simultaneously initiated video recording and timing. The mice freely explored the environment for a 300-s observation period before termination of video capture. Comprehensive sanitization protocols involving 70% ethanol solution were implemented between trials to eliminate olfactory cues from previous subjects, with particular attention given to flooring and vertical surfaces. This procedure was repeated for each mouse. After completing the recordings, we used the AnyMaze software to analyze several key parameters: central zone occupancy duration, ambulatory path length summation, and movement trajectory of the mice over time. These quantitative measurements facilitated comparative evaluation of locomotor activity patterns and anxiety-related behavioral modifications during novel environment exploration.</p>
<p>For the pole descent assessment, the protocol outlined by Ogawa et al. [<a href="#B58" class="usa-link" aria-describedby="B58">58</a>] was implemented with minor modifications. A vertically positioned 50-cm-high plastic rod featuring a coarse surface texture (1.5 mm diameter) served as the climbing apparatus. Experimental animals were gently placed at the structure’s apex in a head-down orientation, with descent duration to the base recorded as the primary measurement. Each subject underwent 3 consecutive trials with an intertrial rest period of 1 min. Subsequent data processing involved computing the mean value from all attempts for analytical purposes, ensuring consistent evaluation metrics across test subjects.</p></section><section id="sec18"><h3 class="pmc_sec_title">Preparation of histological samples</h3>
<p>Animals were heavily anesthetized via intraperitoneal administration of pentobarbital solution (100 mg/kg). A thoracotomy was performed to access the cardiac region, where a perfusion needle was introduced into the left ventricular chamber. Initial perfusion with approximately 20 ml of physiological saline effectively cleared circulatory blood, succeeded by infusion of 50 ml of 0.1 M PBS containing 4% (w/v) paraformaldehyde for tissue fixation. Following craniotomy, the complete cerebral structure was meticulously dissected and transferred to a 4% paraformaldehyde solution for extended post-fixation. Fixed specimens underwent 4 °C storage for 6 to 24 h before immersion in 30% sucrose solution until tissue sedimentation occurred under refrigerated conditions. Cryopreserved samples were embedded in optimal cutting temperature (OCT) medium, with subsequent generation of 40-μm coronal sections using cryosectioning technology. Sectioned tissues underwent triple washing cycles in 0.01 M PBS solution prior to histological processing.</p></section><section id="sec19"><h3 class="pmc_sec_title">Immunofluorescence staining</h3>
<p>For immunofluorescence analysis, tissue sections were initially exposed to 0.01 M PBS supplemented with 1% caprine serum for 40 to 60 min at ambient temperature to prevent unspecific interactions. After blocking, the sections were incubated overnight at 4 °C with the primary antibody mixture diluted in antibody diluent. Post-primary antibody treatment, thorough rinsing with 0.01 M PBS preceded transfer to light-protected secondary antibody solution for 2 to 5 h of ambient temperature incubation. Following final PBS washing cycles, samples were carefully positioned on precleaned microscopy slides under low-light conditions. Complete desiccation preceded application of fluorescence-compatible sealant medium incorporating photobleaching inhibitors (conventional mounting medium for nonfluorescent applications), with subsequent dark storage at 4 °C until microscopic examination.</p></section><section id="sec20"><h3 class="pmc_sec_title">Nissl staining</h3>
<p>For Nissl staining, brain sections obtained from mice were exposed to tar violet solution through incubation at 56 °C for 1 h. Following this process, the slides were rinsed with deionized water to remove excess stain. We then briefly treated the slides with a differentiation solution, monitoring under a light microscope until the background appeared transparent. Sequential dehydration procedures were conducted employing pure ethanol solutions and xylene immersion. Tissue transparency was enhanced through additional xylene treatment before final preservation. The processed sections were permanently sealed using neutral balsam mounting medium for microscopic examination.</p></section><section id="sec21"><h3 class="pmc_sec_title">Hematoxylin and eosin staining</h3>
<p>The tissue samples were immersed in hematoxylin solution for variable durations between 2 and 10 min based on staining requirements. Following hematoxylin application, excess stain was eliminated through multiple distilled water washes. Acidic alcohol solution was subsequently applied for controlled destaining. Specimens then underwent counterstaining in eosin solution for 1- to 5-min intervals before thorough rinsing with purified water. Sequential dehydration was achieved by processing through ascending ethanol concentrations. Final preparation involved immersion in a clearing agent for microscopic evaluation. Throughout the procedure, staining durations were precisely monitored and adjusted according to tissue characteristics.</p></section><section id="sec22"><h3 class="pmc_sec_title">Wright staining</h3>
<p>The Wright stain was formulated by mixing suitable quantities of eosin Y and methylene blue dye in methanol solvent. For cell smear preparations, a few drops of Wright staining solution were applied to cover the entire smear, and the slides were stained for approximately 1 min. An equivalent quantity of PBS was subsequently added to dilute the staining mixture, followed by maintaining the slides undisturbed for 5 to 10 min under ambient temperature conditions. Post-staining procedures involved rigorous rinsing under flowing tap water to remove excess dye, subsequent natural drying of specimens, and final microscopic evaluation.</p></section><section id="sec23"><h3 class="pmc_sec_title">16<em>S</em> rRNA sequencing and data analysis</h3>
<p>The experimental procedures, including sample collection, DNA extraction, amplicon design, PCR amplification, and sequencing, were conducted by Novogene in Beijing, China. Specifically, the microbial community’s total genomic DNA was isolated, with its integrity verified through 1% agarose gel electrophoresis. Quantitative evaluation of DNA concentration and purity measurements were executed using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, USA). Amplification of the 16<em>S</em> rRNA gene’s v3-v4 hypervariable regions was achieved through PCR amplification, employing the isolated DNA as the template with specific primers: the forward primer <em>338F</em> (5′-ACTCCTACGGAGGCAGCAG-3′) and the reverse primer <em>806R</em> (5′-GGACTACHVGGGTWTCTAAT-3′), each containing a unique barcode sequence. Paired-end sequencing data underwent quality assessment via fastp software (<a href="https://github.com/OpenGene/fastp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/OpenGene/fastp</a>, version 0.19.6), followed by sequence assembly using Flash software (<a href="http://www.cbcb.umd.edu/software/flash" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.cbcb.umd.edu/software/flash</a>, version 1.2.11). Further analytical processes were carried out using the NovoMagic bioinformatics platform (<a href="https://magic-plus.novogene.com/#/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://magic-plus.novogene.com/#/</a>).</p></section><section id="sec24"><h3 class="pmc_sec_title">Metabolomics</h3>
<p>Sample preparation, liquid chromatography–tandem mass spectrometry (LC-MS/MS) analysis, compound characterization, and downstream processing were conducted by Novogene (Beijing, China). Solid specimens were homogenized before collecting the supernatant into injection vials equipped with internal cannulae for instrumental analysis. Quality assurance samples were prepared by pooling equivalent volumes of metabolic extracts from all specimens. Metabolic profiling was executed using a Thermo Fisher Scientific UHPLC-Q Exactive HF-X platform coupled with mass spectrometry. Post-acquisition, raw LC-MS data underwent processing through Waters Corporation’s Progenesis QI software (Milford, USA) for baseline correction, peak detection, retention time alignment, and feature integration. A comprehensive data matrix incorporating chromatographic retention parameters, molecular mass-to-charge ratios, and spectral intensities was subsequently constructed. Metabolite annotation involved cross-referencing against established biochemical repositories including HMDB (<a href="http://www.hmdb.ca/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.hmdb.ca/</a>) and METLIN (<a href="https://metlin.scripps.edu/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://metlin.scripps.edu/</a>). Statistical evaluation and data visualization were accomplished through the NovoMagic cloud platform (<a href="https://magic-plus.novogene.com/#/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://magic-plus.novogene.com/#/</a>).</p></section><section id="sec25"><h3 class="pmc_sec_title">Enzyme-Linked Immunosorbent Assay</h3>
<p>The antibody was mixed with coating solution to achieve a protein content ranging from 1 to 10 μg/ml. Each well received 0.1 ml of the prepared test solution, followed by a 1-h incubation period at 37 °C. Post-incubation, all wells underwent thorough rinsing procedures. Subsequently, 0.1 ml of enzyme-conjugated antibody solution (previously optimized through serial dilution) was introduced into each well, with subsequent incubation maintained at 37 °C for 30 to 60 min before another washing cycle. For colorimetric detection, 0.1 ml of freshly made 3,3′,5,5′-tetramethylbenzidine (TMB) chromogenic solution was dispensed into each well, allowing chromogenic development at 37 °C for 10 to 30 min. The enzymatic reaction was terminated through addition of 0.05 ml of 2 M sulfuric acid per well. Ultimately, absorbance measurements at 450-nm wavelength were recorded for quantitative analysis across all test wells.</p></section><section id="sec26"><h3 class="pmc_sec_title">Reverse transcription quantitative polymerase chain reaction</h3>
<p>Total RNA was isolated from cellular samples and murine brain tissues employing an RNA extraction kit in accordance with guidelines provided by the manufacturer. For cDNA synthesis, ribonuclease (RNase)-free PCR tubes were utilized to conduct reverse transcription reactions containing RNA templates, reverse transcriptase enzyme, and specific primers. The qPCR preparation involved sequential addition of reaction mix, primer pairs, diethyl pyrocarbonate (DEPC)-treated water, synthesized cDNA, and supplementary reagents, with careful attention to thorough homogenization without residual droplets on tube surfaces. The reaction mixture was briefly centrifuged and mixed to eliminate any bubbles. The prepared reaction solution was then transferred to the real-time qPCR instrument, where the corresponding temperature cycling and acquisition modes were set. Fluorescence intensity measurements were recorded throughout the amplification cycles, with subsequent data interpretation employing the −ΔΔCt analytical approach for relative quantification. Primer nucleotide sequences used in these amplifications are detailed in Table <a href="#supplementary-material-1" class="usa-link">S2</a>.</p></section><section id="sec27"><h3 class="pmc_sec_title">Cell lines and treatments</h3>
<p>The BV-2 and SN4741 cell lines were maintained in high-glucose DMEM (Dulbecco’s modified Eagle’s medium) containing 10% fetal bovine serum (FBS), along with penicillin (100 U/ml) and streptomycin (100 μg/ml). A humidified environment of 37 °C and 5% CO₂ was used for cell incubation, with complete medium renewal occurring daily. Subculturing procedures were conducted every 2 d. Upon achieving 60% to 70% confluency, cells were transitioned to serum-deprived medium and exposed to varying KYNA concentrations. Inflammatory and toxic responses were triggered through administration of either 1 μg/ml LPS or 1 mM 1-methyl-4-phenylpyridinium (MPP<sup>+</sup>).</p>
<p>For siRNA transfection, siRNA was centrifuged and diluted to a 20 μM stock solution using RNase-free H₂O or sterilized ddH₂O. The siRNA sequence used is as follows: GPR35 siRNA-1 sense 5′-CAUUGUGCCUGACUUUAUA(dTdT)-3′, antisense 5′-TTCGATGCCAGTCGTGC(dTdT)-3′; GPR35 siRNA-2 sense 5′-AGGAGCACCCGGCACAAUUUC(dTdT)-3′, antisense 5′-GAAAUUGUGCCGGGUGCUCCU(dTdT)-3′; GPR35 siRNA-3 sense 5′-CCACAAAAGCCAGGACUCU(dTdT)-3′, antisense 5′-AGAGUCCUGGCUUUUGUGG(dTdT)-3′. Twenty-four hours before transfection, cells were plated to reach 30% to 50% confluency at the time of treatment. For the transfection process, 1.25 μl of siRNA (20 μM stock solution) was diluted in 25 μl of minimal essential medium (Opti-MEM, or DMEM without antibiotics and serum) and combined with 500 ng of plasmid DNA. The mixture was gently pipetted 3 to 5 times to ensure thorough mixing, after which 1.0 μl of EpFed Transfection Reagent (EpFed Biotechnology, Beijing, China) was added. The solution was again gently mixed by pipetting 3 to 5 times, avoiding vortexing or centrifugation. This protocol achieved a final siRNA concentration of 50 nM in cultured cells, followed by a 20-min room temperature incubation period.</p>
<p>For transfection experiments conducted in 24-well plates, each well received 25 μl of a prepared complex comprising transfection reagent combined with siRNA or plasmid DNA, which was distributed uniformly across the culture surface. The plate was then incubated at 37 °C with 5% CO₂ for 48 to 72 h. Gene silencing efficiency was assessed 48 to 72 h post-transfection.</p></section><section id="sec28"><h3 class="pmc_sec_title">Western blottings</h3>
<p>Protein samples were isolated from animal-derived tissues and cellular cultures (BV-2 and SN4741). Tissue specimens and cell pellets were chemically disrupted using NP-40 Lysis Buffer, after which the homogenates were centrifuged at 12,000<em>g</em> for 10 min under refrigerated conditions (4 °C). Protein levels were quantified with the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) following standardized protocols. Subsequently, protein aliquots were mixed with β-mercaptoethanol–containing solution, dissolved in 5× sodium dodecyl sulfate (SDS) loading buffer, and normalized to 20 μg per well for electrophoretic analysis. Thermal denaturation was performed by heating samples at boiling temperature (100 °C) for 5 to 7 min prior to electrophoretic separation. Electrophoresis was conducted using SDS-polyacrylamide gels, followed by protein transfer to polyvinylidene fluoride (PVDF) membranes using standard immunoblotting techniques. Membranes were initially saturated for 120 min with tris-buffered saline with Tween 20 containing 5% nonfat dairy powder. Primary antibody incubation (targeting iNOS and COX-2; refer to the Supplementary Materials) proceeded overnight at 4 °C, succeeded by exposure to horseradish peroxidase-linked secondary antibodies. Detection was achieved through enhanced chemiluminescence substrate reaction, with chemiluminescent signals captured using a Tanon G2500 imaging system (Tanon, Shanghai) following appropriate exposure durations.</p></section><section id="sec29"><h3 class="pmc_sec_title">Detection of oxidative stress markers</h3>
<p>Oxidative stress markers were assessed according to the protocols provided by the respective assay kits: the mitochondrial membrane potential assay kit with JC-1, the Total Antioxidant Capacity Assay Kit (FRAP method, S0116, Beyotime), the Reactive Oxygen Species Assay Kit (S0033S, Beyotime), the Total Superoxide Dismutase Assay Kit (WST-8 method, S0101S, Beyotime), the Catalase Assay Kit (S0051, Beyotime), the reduced glutathione and oxidized glutathione disulfide (GSSG) Assay Kit (S0053, Beyotime), and the Lipid Peroxidation Assay Kit (S0131S, Beyotime). Measurements were performed using an iMark Microplate Absorbance Reader (Bio-Rad Laboratories, Hercules, CA, USA). The sample quantity was determined according to the precise instructions provided with each kit.</p></section><section id="sec30"><h3 class="pmc_sec_title">Cell viability assay</h3>
<p>The CCK-8 assay was employed to evaluate cell viability. BV-2 and SN4741 cells were plated into 96-well microplates, allocating 5 to 10 wells per experimental group. Following a 24-h incubation period, cellular populations were categorized into control and treatment cohorts, where the latter received different drug dosage levels. Medium replacement was performed using fresh culture solution containing 10% CCK-8 reagent. Microplates underwent 1 to 4 h of incubation. Optical density readings were recorded hourly at 450 nm, using 630 nm as the reference wavelength. Viability percentages were determined through the following formula: (Experimental group OD value ÷ Control group OD value) × 100%.</p></section><section id="sec31"><h3 class="pmc_sec_title">LDH activity</h3>
<p>Cells were plated in a 96-well plate at a concentration of 5 × 10<sup>5</sup> cells/ml, with each well receiving 100 μl of cellular suspension. Experimental compounds were subsequently introduced into designated wells, and a control group was included for comparison. The plates underwent incubation in a culture chamber for 1 to 5 h. Post-incubation, the medium was carefully removed before adding 100 μl of LDH assay working solution per well. The mixture was incubated under light-protected conditions for 5 to 30 min to facilitate the reaction. Following this, 50 μl of termination reagent was dispensed into each well to terminate the enzymatic activity. Optical density values were subsequently recorded at wavelengths of 490 or 565 nm using a plate spectrophotometer for subsequent cytotoxicity assessment.</p></section><section id="sec32"><h3 class="pmc_sec_title">Transmission electron microscopy</h3>
<p>The culture medium was removed, and cellular fixation was performed using 2.5% glutaraldehyde solution maintained at 4 °C for 15 min. Following detachment, the cells were pelleted via centrifugation while preserving the fixation solution. The resulting cellular aggregates were subsequently maintained under refrigeration at 4 °C. A series of four 15-min washing cycles with 0.1 M PBS was implemented. Subsequent secondary fixation involved treatment with 1% osmium tetroxide prepared in 0.1 M PBS (pH 7.2) under ambient conditions (20 °C) for a 4-h duration. Triple washing procedures employing PBS were conducted, each cycle maintained for 15 min. Sequential dehydration processes were executed using ethanol and acetone solutions, followed by cellular permeabilization achieved through combined acetone and epoxy resin treatment.</p>
<p>The treated specimens were positioned in encapsulation containers or embedding chambers, with subsequent introduction of epoxy-based embedding medium. Polymerization processing was implemented through thermal curing at 60 °C maintained for 48 h. Post-curing preparation involved microtome sectioning to achieve 70-nm thin slices, which subsequently underwent dual-staining protocol: Initial treatment with uranyl acetate (2% aqueous saturation concentration) succeeded by lead citrate application, both conducted under ambient conditions for 15-min durations. Section dehydration was accomplished through natural air-drying over 24-h period at standard laboratory temperature. Ultrastructural examination was ultimately performed utilizing TEM equipment.</p></section><section id="sec33"><h3 class="pmc_sec_title">Proteomics by LC-MS/MS</h3>
<p>Following cell scraping, a lysate solution (8 M urea with 1% SDS supplemented with protease inhibitors) was introduced to resuspend the cellular material. The combined sample underwent mechanical disruption through 3 iterative 40-s treatments in a high-throughput tissue homogenizer. Quantitative analysis of protein content was conducted via bicinchoninic acid assay (BCA) method. Proteins then underwent sequential reduction, alkylation, and enzymatic digestion processes. Final peptide concentrations were measured according to manufacturer protocols specified in the Peptide Quantification Kit (Thermo Fisher Scientific, catalog no. 23275), employing established spectrophotometric techniques.</p>
<p>Following dissolution of peptide samples in appropriate mass spectrometry buffer, analytical separation and detection were performed using an EASY-nLC 1200 nanoflow liquid chromatography system paired with a Q Exactive HF-X hybrid quadrupole-orbitrap mass spectrometer in MS/MS mode. All raw spectral data were subsequently transferred to the Majorbio cloud-based analysis platform (accessible at <a href="http://cloud.majorbio.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">cloud.majorbio.com</a>) for comprehensive processing. Intergroup comparative analysis involving both statistical significance (expressed as <em>P</em> values) and quantitative fold-change differences was executed through implementation of Student’s <em>t</em> test methodology.</p></section><section id="sec34"><h3 class="pmc_sec_title">RNA sequencing</h3>
<p>Total RNA was isolated from cellular specimens, with quantification of nucleic acid concentration and assessment of purity conducted via NanoDrop 2000 spectrophotometric analysis (Thermo Fisher Scientific, Waltham, MA, USA). Electrophoretic separation on agarose matrices was employed to evaluate RNA integrity, complemented by RNA quality number (RQN) determination using the Agilent 5300 analytical platform. Oligo(dT)-functionalized magnetic beads facilitated selective mRNA enrichment through complementary A–T base pairing with polyadenylated termini, enabling effective separation from ribosomal and noncoding RNA species. Enzymatic fragmentation protocols were implemented to generate randomly distributed RNA segments averaging 300 base pairs. First-strand cDNA synthesis was initiated using reverse transcriptase, followed by second-strand synthesis to produce double-stranded DNA fragments. Terminal repair reactions utilizing specialized enzyme mixtures converted cohesive ends to blunt termini, succeeded by 3′-terminal adenosine addition to facilitate adapter ligation. Post-ligation purification processes eliminated unbound adapters, with subsequent size selection optimizing fragment distributions. Amplification through thermocyclic PCRs yielded sequencing-ready libraries, which underwent final quality control assessments prior to high-throughput sequencing on the NovaSeq X Plus instrumentation (Illumina, San Diego, CA, USA).</p></section><section id="sec35"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>To determine the significance of differences between experimental groups, statistical analyses were conducted. A one-way analysis of variance (ANOVA) was utilized for comparing means ± SEM obtained from 3 separate experiments. A significance threshold of <em><sup>*</sup>P</em> &lt; 0.05 was applied to identify statistical differences. All statistical evaluations were carried out with GraphPad Prism 10 (GraphPad Software, San Diego, CA, USA).</p></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We thank F. Shoupeng and G. Wenjin for their technical support for this article. We also thank <a href="http://BioRender.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">BioRender.com</a> for its support in generating charts and the Veterinary College of Jilin University for its support in instrumentation.</p>
<p><strong>Funding:</strong> The work was supported by the National Key Research and Development Program of China (2024YFA0919800), the National Natural Science Foundation of China (32371470 and 82341019), the Guangdong Provincial Key-Area R&amp;D Program (2023B0909020003), the SMART Program (B2402009), and the Shenzhen Fundamental Research Program (Natural Science Foundation) (JCYJ20241202123909013).</p>
<p><strong>Author contributions:</strong> T.M. and Y.Z. conducted experiments, discussed, bioinformatic analyzed, analyzed data, and wrote the first draft. T.M., S.F. and S.M. conceived and supervised the study. Y.Z. designed and interpreted the results. S.M. provided reagents or technical support, reviewed and edited the manuscript, and was the primary contact for communication and the guarantor of the study.</p>
<p><strong>Competing interests:</strong> The authors declare that they have no competing interests.</p></section><section id="sec36"><h2 class="pmc_sec_title">Data Availability</h2>
<p>Data are available upon reasonable request. All data are available in the main text or Supplementary Materials. Correspondence and requests for materials should be addressed to S.M. (<span>ma.shaohua@sz.tsinghua.edu.cn</span>) on reasonable request.</p></section><section id="supplementary-material-1"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="supp-1"><div class="caption p">
<span>Supplementary 1</span><p>Tables S1 and S2</p>
<p>Figs. S1 to S8</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12376290/bin/research.0846.f1.docx" data-ga-action="click_feat_suppl" class="usa-link">research.0846.f1.docx</a><sup> (30.9MB, docx) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>Tolosa E, Garrido A, Scholz SW, Poewe W. 
Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol. 2021;20(5):385–397.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(21)00030-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8185633/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33894193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Neurol&amp;title=Challenges%20in%20the%20diagnosis%20of%20Parkinson%E2%80%99s%20disease&amp;volume=20&amp;issue=5&amp;publication_year=2021&amp;pages=385-397&amp;pmid=33894193&amp;doi=10.1016/S1474-4422(21)00030-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>Atik A, Stewart T, Zhang J. 
Alpha-synuclein as a biomarker for Parkinson’s disease. Brain Pathol. 2016;26(3):410–418.
</cite> [<a href="https://doi.org/10.1111/bpa.12370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6245641/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26940058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Pathol&amp;title=Alpha-synuclein%20as%20a%20biomarker%20for%20Parkinson%E2%80%99s%20disease&amp;volume=26&amp;issue=3&amp;publication_year=2016&amp;pages=410-418&amp;pmid=26940058&amp;doi=10.1111/bpa.12370&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>Zheng Q, Liu H, Gao Y, Cao G, Wang Y, Li Z. 
Ameliorating mitochondrial dysfunction for the therapy of Parkinson’s disease. Small. 2024;20(29):
Article e2311571.
</cite> [<a href="https://doi.org/10.1002/smll.202311571" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38385823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Small&amp;title=Ameliorating%20mitochondrial%20dysfunction%20for%20the%20therapy%20of%20Parkinson%E2%80%99s%20disease&amp;volume=20&amp;issue=29&amp;publication_year=2024&amp;pages=Article%20e2311571&amp;pmid=38385823&amp;doi=10.1002/smll.202311571&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>Trist BG, Hare DJ, Double KL. 
Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell. 2019;18(6):
Article e13031.
</cite> [<a href="https://doi.org/10.1111/acel.13031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6826160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31432604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aging%20Cell&amp;title=Oxidative%20stress%20in%20the%20aging%20substantia%20nigra%20and%20the%20etiology%20of%20Parkinson%E2%80%99s%20disease&amp;volume=18&amp;issue=6&amp;publication_year=2019&amp;pages=Article%20e13031&amp;pmid=31432604&amp;doi=10.1111/acel.13031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L, Sun Y, Wu J, Zhou Q, Huang J, et al. 
Targeting microglial α-synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson’s disease. Front Immunol. 2021;12:
Article 719807.
</cite> [<a href="https://doi.org/10.3389/fimmu.2021.719807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8531525/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34691027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Targeting%20microglial%20%CE%B1-synuclein/TLRs/NF-kappaB/NLRP3%20inflammasome%20axis%20in%20Parkinson%E2%80%99s%20disease&amp;volume=12&amp;publication_year=2021&amp;pages=Article%20719807&amp;pmid=34691027&amp;doi=10.3389/fimmu.2021.719807&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>Wang T, Shi C, Luo H, Zheng H, Fan L, Tang M, Su Y, Yang J, Mao C, Xu Y. 
Neuroinflammation in Parkinson’s disease: Triggers, mechanisms, andImmunotherapies. Neuroscientist. 2022;28(4):364–381.
</cite> [<a href="https://doi.org/10.1177/1073858421991066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33576313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscientist&amp;title=Neuroinflammation%20in%20Parkinson%E2%80%99s%20disease:%20Triggers,%20mechanisms,%20andImmunotherapies&amp;volume=28&amp;issue=4&amp;publication_year=2022&amp;pages=364-381&amp;pmid=33576313&amp;doi=10.1177/1073858421991066&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>Liu TW, Chen CM, Chang KH. 
Biomarker of Neuroinflammation in Parkinson’s disease. Int J Mol Sci. 2022;23(8):
Article 4148.
</cite> [<a href="https://doi.org/10.3390/ijms23084148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9028544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35456966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Biomarker%20of%20Neuroinflammation%20in%20Parkinson%E2%80%99s%20disease&amp;volume=23&amp;issue=8&amp;publication_year=2022&amp;pages=Article%204148&amp;pmid=35456966&amp;doi=10.3390/ijms23084148&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D. 
Fecal microbiota transplantation protects rotenone-induced Parkinson’s diseasemice via suppressing inflammation mediated by the lipopolysaccharide-TLR4signaling pathway through the microbiota-gut-brain axis. Microbiome. 2021;9(1):226.
</cite> [<a href="https://doi.org/10.1186/s40168-021-01107-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8597301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34784980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Microbiome&amp;title=Fecal%20microbiota%20transplantation%20protects%20rotenone-induced%20Parkinson%E2%80%99s%20diseasemice%20via%20suppressing%20inflammation%20mediated%20by%20the%20lipopolysaccharide-TLR4signaling%20pathway%20through%20the%20microbiota-gut-brain%20axis&amp;volume=9&amp;issue=1&amp;publication_year=2021&amp;pages=226&amp;pmid=34784980&amp;doi=10.1186/s40168-021-01107-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>Mulak A, Bonaz B. 
Brain-gut-microbiota axis in Parkinson’s disease. World J Gastroenterol. 2015;21(37):10609–10620.
</cite> [<a href="https://doi.org/10.3748/wjg.v21.i37.10609" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4588083/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26457021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20J%20Gastroenterol&amp;title=Brain-gut-microbiota%20axis%20in%20Parkinson%E2%80%99s%20disease&amp;volume=21&amp;issue=37&amp;publication_year=2015&amp;pages=10609-10620&amp;pmid=26457021&amp;doi=10.3748/wjg.v21.i37.10609&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, Poleszak E, Fichna J, Wlaź P. 
The role of microbiota-gut-brain axis in neuropsychiatric and neurologicaldisorders. Pharmacol Res. 2021;172:
Article 105840.
</cite> [<a href="https://doi.org/10.1016/j.phrs.2021.105840" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34450312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol%20Res&amp;title=The%20role%20of%20microbiota-gut-brain%20axis%20in%20neuropsychiatric%20and%20neurologicaldisorders&amp;volume=172&amp;publication_year=2021&amp;pages=Article%20105840&amp;pmid=34450312&amp;doi=10.1016/j.phrs.2021.105840&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>Li Z, Liang H, Hu Y, Lu L, Zheng C, Fan Y, Wu B, Zou T, Luo X, Zhang X, et al. 
Gut bacterial profiles in Parkinson’s disease: A systematic review. CNS Neurosci Ther. 2023;29(1):140–157.
</cite> [<a href="https://doi.org/10.1111/cns.13990" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9804059/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36284437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CNS%20Neurosci%20Ther&amp;title=Gut%20bacterial%20profiles%20in%20Parkinson%E2%80%99s%20disease:%20A%20systematic%20review&amp;volume=29&amp;issue=1&amp;publication_year=2023&amp;pages=140-157&amp;pmid=36284437&amp;doi=10.1111/cns.13990&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>Xiao W, Su J, Gao X, Yang H, Weng R, Ni W, Gu Y. 
The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion bydisrupting the metabolism of short-chain fatty acids. Microbiome. 2022;10(1):
Article 62.
</cite> [<a href="https://doi.org/10.1186/s40168-022-01255-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9013454/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35430804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Microbiome&amp;title=The%20microbiota-gut-brain%20axis%20participates%20in%20chronic%20cerebral%20hypoperfusion%20bydisrupting%20the%20metabolism%20of%20short-chain%20fatty%20acids&amp;volume=10&amp;issue=1&amp;publication_year=2022&amp;pages=Article%2062&amp;pmid=35430804&amp;doi=10.1186/s40168-022-01255-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>Yu H, Chang Q, Sun T, He X, Wen L, An J, Feng J, Zhao Y. 
Metabolic reprogramming and polarization of microglia in Parkinson’s disease:Role of inflammasome and iron. Ageing Res Rev. 2023;90:
Article 102032.
</cite> [<a href="https://doi.org/10.1016/j.arr.2023.102032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37572760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ageing%20Res%20Rev&amp;title=Metabolic%20reprogramming%20and%20polarization%20of%20microglia%20in%20Parkinson%E2%80%99s%20disease:Role%20of%20inflammasome%20and%20iron&amp;volume=90&amp;publication_year=2023&amp;pages=Article%20102032&amp;pmid=37572760&amp;doi=10.1016/j.arr.2023.102032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>Shi M, Yang J, Liu Y, Zhao H, Li M, Yang D, Xie Q. 
Huanglian Wendan decoction improves insomnia in rats by regulating BDNF/TrkB signaling pathway through gut microbiota-mediated SCFAs and affecting microglia polarization. Mol Neurobiol. 2025;62(1):1047–1066.
</cite> [<a href="https://doi.org/10.1007/s12035-024-04330-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38954253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Neurobiol&amp;title=Huanglian%20Wendan%20decoction%20improves%20insomnia%20in%20rats%20by%20regulating%20BDNF/TrkB%20signaling%20pathway%20through%20gut%20microbiota-mediated%20SCFAs%20and%20affecting%20microglia%20polarization&amp;volume=62&amp;issue=1&amp;publication_year=2025&amp;pages=1047-1066&amp;pmid=38954253&amp;doi=10.1007/s12035-024-04330-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>Dorsam RT, Gutkind JS. 
G-protein-coupled receptors and cancer. Nat Rev Cancer. 2007;7(2):79–94.
</cite> [<a href="https://doi.org/10.1038/nrc2069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17251915/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=G-protein-coupled%20receptors%20and%20cancer&amp;volume=7&amp;issue=2&amp;publication_year=2007&amp;pages=79-94&amp;pmid=17251915&amp;doi=10.1038/nrc2069&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>Schmitz GP, Roth BL. 
G protein-coupled receptors as targets for transformative neuropsychiatrictherapeutics. Am J Physiol Cell Physiol. 2023;325(1):C17–C28.
</cite> [<a href="https://doi.org/10.1152/ajpcell.00397.2022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10281788/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37067459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Physiol%20Cell%20Physiol&amp;title=G%20protein-coupled%20receptors%20as%20targets%20for%20transformative%20neuropsychiatrictherapeutics&amp;volume=325&amp;issue=1&amp;publication_year=2023&amp;pages=C17-C28&amp;pmid=37067459&amp;doi=10.1152/ajpcell.00397.2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>Wu Y, Zhang P, Fan H, Zhang C, Yu P, Liang X, Chen Y. 
GPR35 acts a dual role and therapeutic target in inflammation. Front Immunol. 2023;14:
Article 1254446.
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1254446" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10687457/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38035084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=GPR35%20acts%20a%20dual%20role%20and%20therapeutic%20target%20in%20inflammation&amp;volume=14&amp;publication_year=2023&amp;pages=Article%201254446&amp;pmid=38035084&amp;doi=10.3389/fimmu.2023.1254446&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>Wyant GA, Yu W, Doulamis IP, Nomoto RS, Saeed MY, Duignan T, McCully J, Kaelin WG Jr. 
Mitochondrial remodeling and ischemic protection by G protein-coupled receptor 35 agonists. Science. 2022;377(6606):621–629.
</cite> [<a href="https://doi.org/10.1126/science.abm1638" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9639781/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35926043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Mitochondrial%20remodeling%20and%20ischemic%20protection%20by%20G%20protein-coupled%20receptor%2035%20agonists&amp;volume=377&amp;issue=6606&amp;publication_year=2022&amp;pages=621-629&amp;pmid=35926043&amp;doi=10.1126/science.abm1638&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>Takkar S, Sharma G, Kaushal JB, Abdullah KM, Batra SK, Siddiqui JA. 
From orphan to oncogene: The role of GPR35 in cancer and immune modulation. Cytokine Growth Factor Rev. 2024;77:56–66.
</cite> [<a href="https://doi.org/10.1016/j.cytogfr.2024.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11793123/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38514303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cytokine%20Growth%20Factor%20Rev&amp;title=From%20orphan%20to%20oncogene:%20The%20role%20of%20GPR35%20in%20cancer%20and%20immune%20modulation&amp;volume=77&amp;publication_year=2024&amp;pages=56-66&amp;pmid=38514303&amp;doi=10.1016/j.cytogfr.2024.03.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>Kaya B, Melhem H, Niess JH. 
GPR35 in intestinal diseases: From risk gene to function. Front Immunol. 2021;12:
Article 717392.
</cite> [<a href="https://doi.org/10.3389/fimmu.2021.717392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8591220/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34790192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=GPR35%20in%20intestinal%20diseases:%20From%20risk%20gene%20to%20function&amp;volume=12&amp;publication_year=2021&amp;pages=Article%20717392&amp;pmid=34790192&amp;doi=10.3389/fimmu.2021.717392&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>Chen K, He L, Li Y, Li X, Qiu C, Pei H, Yang D. 
Inhibition of GPR35 preserves mitochondrial function after myocardial infarction by targeting calpain 1/2. J Cardiovasc Pharmacol. 2020;75(6):556–563.
</cite> [<a href="https://doi.org/10.1097/FJC.0000000000000819" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7266003/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32195756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cardiovasc%20Pharmacol&amp;title=Inhibition%20of%20GPR35%20preserves%20mitochondrial%20function%20after%20myocardial%20infarction%20by%20targeting%20calpain%201/2&amp;volume=75&amp;issue=6&amp;publication_year=2020&amp;pages=556-563&amp;pmid=32195756&amp;doi=10.1097/FJC.0000000000000819&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>Kaya B, Doñas C, Wuggenig P, Diaz OE, Morales RA, Melhem H, Hernández PP, Kaymak T, Das S, Hruz P, et al. 
Lysophosphatidic acid-mediated GPR35 signaling in CX3CR1<sup>+</sup> macrophages regulates intestinal homeostasis. Cell Rep. 2020;32(5):
Article 107979.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2020.107979" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32755573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Rep&amp;title=Lysophosphatidic%20acid-mediated%20GPR35%20signaling%20in%20CX3CR1+%20macrophages%20regulates%20intestinal%20homeostasis&amp;volume=32&amp;issue=5&amp;publication_year=2020&amp;pages=Article%20107979&amp;pmid=32755573&amp;doi=10.1016/j.celrep.2020.107979&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>Agudelo LZ, Ferreira D, Cervenka I, Bryzgalova G, Dadvar S, Jannig PR, Pettersson-Klein AT, Lakshmikanth T, Sustarsic EG, Porsmyr-Palmertz M, et al. 
Kynurenic acid and Gpr35 regulate adipose tissue energy homeostasis and inflammation. Cell Metab. 2018;27(2):378–392.e5.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2018.01.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29414686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Metab&amp;title=Kynurenic%20acid%20and%20Gpr35%20regulate%20adipose%20tissue%20energy%20homeostasis%20and%20inflammation&amp;volume=27&amp;issue=2&amp;publication_year=2018&amp;pages=378-392.e5&amp;pmid=29414686&amp;doi=10.1016/j.cmet.2018.01.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>Butler MI, Bastiaanssen TF, Long-Smith C, Morkl S, Berding K, Ritz NL, Strain C, Patangia D, Patel S, Stanton C, et al. 
The gut microbiome in social anxiety disorder: Evidence of altered compositionand function. Transl Psychiatry. 2023;13(1):
Article 95.
</cite> [<a href="https://doi.org/10.1038/s41398-023-02325-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10027687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36941248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transl%20Psychiatry&amp;title=The%20gut%20microbiome%20in%20social%20anxiety%20disorder:%20Evidence%20of%20altered%20compositionand%20function&amp;volume=13&amp;issue=1&amp;publication_year=2023&amp;pages=Article%2095&amp;pmid=36941248&amp;doi=10.1038/s41398-023-02325-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>Huang C, Li Y, Feng X, Li D, Li X, Ouyang Q, Dai W, Wu G, Zhou Q, Wang P, et al. 
Distinct gut microbiota composition and functional category in children with cerebral palsy and epilepsy. Front Pediatr. 2019;7:
Article 394.
</cite> [<a href="https://doi.org/10.3389/fped.2019.00394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6779726/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31646147/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pediatr&amp;title=Distinct%20gut%20microbiota%20composition%20and%20functional%20category%20in%20children%20with%20cerebral%20palsy%20and%20epilepsy&amp;volume=7&amp;publication_year=2019&amp;pages=Article%20394&amp;pmid=31646147&amp;doi=10.3389/fped.2019.00394&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>Kalia LV, Lang AE. 
Parkinson’s disease. Lancet. 2015;386(9996):896–912.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(14)61393-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25904081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Parkinson%E2%80%99s%20disease&amp;volume=386&amp;issue=9996&amp;publication_year=2015&amp;pages=896-912&amp;pmid=25904081&amp;doi=10.1016/S0140-6736(14)61393-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>Kam TI, Hinkle JT, Dawson TM, Dawson VL. 
Microglia and astrocyte dysfunction in Parkinson’s disease. Neurobiol Dis. 2020;144:
Article 105028.
</cite> [<a href="https://doi.org/10.1016/j.nbd.2020.105028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7484088/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32736085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurobiol%20Dis&amp;title=Microglia%20and%20astrocyte%20dysfunction%20in%20Parkinson%E2%80%99s%20disease&amp;volume=144&amp;publication_year=2020&amp;pages=Article%20105028&amp;pmid=32736085&amp;doi=10.1016/j.nbd.2020.105028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>Badanjak K, Fixemer S, Smajić S, Skupin A, Grünewald A. 
The contribution of microglia to neuroinflammation in Parkinson’s disease. Int J Mol Sci. 2021;22(9):
Article 4676.
</cite> [<a href="https://doi.org/10.3390/ijms22094676" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8125756/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33925154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=The%20contribution%20of%20microglia%20to%20neuroinflammation%20in%20Parkinson%E2%80%99s%20disease&amp;volume=22&amp;issue=9&amp;publication_year=2021&amp;pages=Article%204676&amp;pmid=33925154&amp;doi=10.3390/ijms22094676&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>Melhem H, Kaya B, Kaymak T, Wuggenig P, Flint E, Roux J, Oost KC, Cavelti-Weder C, Balmer ML, Walser JC, et al. 
Epithelial GPR35 protects from Citrobacter rodentium infection by preserving goblet cells and mucosal barrier integrity. Mucosal Immunol. 2022;15(3):443–458.
</cite> [<a href="https://doi.org/10.1038/s41385-022-00494-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9038528/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35264769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mucosal%20Immunol&amp;title=Epithelial%20GPR35%20protects%20from%20Citrobacter%20rodentium%20infection%20by%20preserving%20goblet%20cells%20and%20mucosal%20barrier%20integrity&amp;volume=15&amp;issue=3&amp;publication_year=2022&amp;pages=443-458&amp;pmid=35264769&amp;doi=10.1038/s41385-022-00494-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>Cheng L, Wu H, Cai X, Zhang Y, Yu S, Hou Y, Yin Z, Yan Q, Wang Q, Sun T, et al. 
A Gpr35-tuned gut microbe-brain metabolic axis regulates depressive-like behavior. Cell Host Microbe. 2024;32(2):227–243.
</cite> [<a href="https://doi.org/10.1016/j.chom.2023.12.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38198925/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Host%20Microbe&amp;title=A%20Gpr35-tuned%20gut%20microbe-brain%20metabolic%20axis%20regulates%20depressive-like%20behavior&amp;volume=32&amp;issue=2&amp;publication_year=2024&amp;pages=227-243&amp;pmid=38198925&amp;doi=10.1016/j.chom.2023.12.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>Salim S, Ahmad F, Banu A, Mohammad F. 
Gut microbiome and Parkinson’s disease: Perspective on pathogenesis and treatment. J Adv Res. 2023;50:83–105.
</cite> [<a href="https://doi.org/10.1016/j.jare.2022.10.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10403695/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36332796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Adv%20Res&amp;title=Gut%20microbiome%20and%20Parkinson%E2%80%99s%20disease:%20Perspective%20on%20pathogenesis%20and%20treatment&amp;volume=50&amp;publication_year=2023&amp;pages=83-105&amp;pmid=36332796&amp;doi=10.1016/j.jare.2022.10.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>Ayten S, Bilici S. 
Modulation of gut microbiota through dietary intervention in neuroinflammation and Alzheimer’s and Parkinson’s diseases. Curr Nutr Rep. 2024;13(2):82–96.
</cite> [<a href="https://doi.org/10.1007/s13668-024-00539-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11133127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38652236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Nutr%20Rep&amp;title=Modulation%20of%20gut%20microbiota%20through%20dietary%20intervention%20in%20neuroinflammation%20and%20Alzheimer%E2%80%99s%20and%20Parkinson%E2%80%99s%20diseases&amp;volume=13&amp;issue=2&amp;publication_year=2024&amp;pages=82-96&amp;pmid=38652236&amp;doi=10.1007/s13668-024-00539-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>Warnecke T, Schafer KH, Claus I, Del TK, Jost WH. 
Gastrointestinal involvement in Parkinson’s disease: Pathophysiology, diagnosis, and management. NPJ Parkinsons Dis. 2022;8(1):
Article 31.</cite> [<a href="https://doi.org/10.1038/s41531-022-00295-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8948218/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35332158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NPJ%20Parkinsons%20Dis&amp;title=Gastrointestinal%20involvement%20in%20Parkinson%E2%80%99s%20disease:%20Pathophysiology,%20diagnosis,%20and%20management&amp;volume=8&amp;issue=1&amp;publication_year=2022&amp;pages=Article%2031&amp;pmid=35332158&amp;doi=10.1038/s41531-022-00295-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>Chen C, Liao J, Xia Y, Liu X, Jones R, Haran J, McCormick B, Sampson TR, Alam A, Ye K. 
Gut microbiota regulate Alzheimer’s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut. 2022;71(11):2233–2252.
</cite> [<a href="https://doi.org/10.1136/gutjnl-2021-326269" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10720732/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35017199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Gut%20microbiota%20regulate%20Alzheimer%E2%80%99s%20disease%20pathologies%20and%20cognitive%20disorders%20via%20PUFA-associated%20neuroinflammation&amp;volume=71&amp;issue=11&amp;publication_year=2022&amp;pages=2233-2252&amp;pmid=35017199&amp;doi=10.1136/gutjnl-2021-326269&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>Wang L, Zhao Z, Zhao L, Zhao Y, Yang G, Wang C, Gao L, Niu C, Li S. 
Lactobacillus plantarum DP189 reduces alpha-SYN aggravation in MPTP-induced Parkinson’s disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder. J Agr Food Chem. 2022;70(4):1163–1173.
</cite> [<a href="https://doi.org/10.1021/acs.jafc.1c07711" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35067061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Agr%20Food%20Chem&amp;title=Lactobacillus%20plantarum%20DP189%20reduces%20alpha-SYN%20aggravation%20in%20MPTP-induced%20Parkinson%E2%80%99s%20disease%20mice%20via%20regulating%20oxidative%20damage,%20inflammation,%20and%20gut%20microbiota%20disorder&amp;volume=70&amp;issue=4&amp;publication_year=2022&amp;pages=1163-1173&amp;pmid=35067061&amp;doi=10.1021/acs.jafc.1c07711&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. 
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA. 2011;108(38):16050–16055.
</cite> [<a href="https://doi.org/10.1073/pnas.1102999108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3179073/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21876150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&amp;title=Ingestion%20of%20Lactobacillus%20strain%20regulates%20emotional%20behavior%20and%20central%20GABA%20receptor%20expression%20in%20a%20mouse%20via%20the%20vagus%20nerve&amp;volume=108&amp;issue=38&amp;publication_year=2011&amp;pages=16050-16055&amp;pmid=21876150&amp;doi=10.1073/pnas.1102999108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>Ibrahim A, Ali RA, Manaf MR, Ahmad N, Tajurruddin FW, Qin WZ, Desa SH, Ibrahim NM. 
Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson’s disease: A randomised controlled trial. PLOS ONE. 2020;15(12):
Article e244680.</cite> [<a href="https://doi.org/10.1371/journal.pone.0244680" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7774928/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33382780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLOS%20ONE&amp;title=Multi-strain%20probiotics%20(Hexbio)%20containing%20MCP%20BCMC%20strains%20improved%20constipation%20and%20gut%20motility%20in%20Parkinson%E2%80%99s%20disease:%20A%20randomised%20controlled%20trial&amp;volume=15&amp;issue=12&amp;publication_year=2020&amp;pages=Article%20e244680&amp;pmid=33382780&amp;doi=10.1371/journal.pone.0244680&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>Qu R, Zhang Y, Ma Y, Zhou X, Sun L, Jiang C, Zhang Z, Fu W. 
Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer. Adv Sci. 2023;10(23):
Article e2205563.</cite> [<a href="https://doi.org/10.1002/advs.202205563" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10427379/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37263983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv%20Sci&amp;title=Role%20of%20the%20gut%20microbiota%20and%20its%20metabolites%20in%20tumorigenesis%20or%20development%20of%20colorectal%20cancer&amp;volume=10&amp;issue=23&amp;publication_year=2023&amp;pages=Article%20e2205563&amp;pmid=37263983&amp;doi=10.1002/advs.202205563&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>Bender MJ, McPherson AC, Phelps CM, Pandey SP, Laughlin CR, Shapira JH, Medina Sanchez L, Rana M, Richie TG, Mims TS, et al. 
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell. 2023;186(9):1846–1862.
</cite> [<a href="https://doi.org/10.1016/j.cell.2023.03.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10148916/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37028428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Dietary%20tryptophan%20metabolite%20released%20by%20intratumoral%20Lactobacillus%20reuteri%20facilitates%20immune%20checkpoint%20inhibitor%20treatment&amp;volume=186&amp;issue=9&amp;publication_year=2023&amp;pages=1846-1862&amp;pmid=37028428&amp;doi=10.1016/j.cell.2023.03.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>Sun M, Ma N, He T, Johnston LJ, Ma X. 
Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR). Crit Rev Food Sci. 2020;60(10):1760–1768.</cite> [<a href="https://doi.org/10.1080/10408398.2019.1598334" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30924357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Rev%20Food%20Sci&amp;title=Tryptophan%20(Trp)%20modulates%20gut%20homeostasis%20via%20aryl%20hydrocarbon%20receptor%20(AhR)&amp;volume=60&amp;issue=10&amp;publication_year=2020&amp;pages=1760-1768&amp;pmid=30924357&amp;doi=10.1080/10408398.2019.1598334&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<span class="label">41.</span><cite>Hong R, Luo L, Wang L, Hu ZL, Yin QR, Li M, Gu B, Wang B, Zhuang T, Zhang XY, et al. 
Lepidium meyenii Walp (Maca)-derived extracellular vesicles ameliorate depressionby promoting 5-HT synthesis via the modulation of gut-brain axis. iMeta. 2023;2(3):
Article e116.
</cite> [<a href="https://doi.org/10.1002/imt2.116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10989901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38867934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=iMeta&amp;title=Lepidium%20meyenii%20Walp%20(Maca)-derived%20extracellular%20vesicles%20ameliorate%20depressionby%20promoting%205-HT%20synthesis%20via%20the%20modulation%20of%20gut-brain%20axis&amp;volume=2&amp;issue=3&amp;publication_year=2023&amp;pages=Article%20e116&amp;pmid=38867934&amp;doi=10.1002/imt2.116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<span class="label">42.</span><cite>Szigetvari PD, Patil S, Birkeland E, Kleppe R, Haavik J. 
The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 andcomorbid neurodevelopmental disorders. Neurochem Int. 2023;171:
Article 105629.
</cite> [<a href="https://doi.org/10.1016/j.neuint.2023.105629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37865339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurochem%20Int&amp;title=The%20effects%20of%20phenylalanine%20and%20tyrosine%20levels%20on%20dopamine%20production%20in%20rat%20PC12%20cells.%20Implications%20for%20treatment%20of%20phenylketonuria,%20tyrosinemia%20type%201%20andcomorbid%20neurodevelopmental%20disorders&amp;volume=171&amp;publication_year=2023&amp;pages=Article%20105629&amp;pmid=37865339&amp;doi=10.1016/j.neuint.2023.105629&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<span class="label">43.</span><cite>Mak J, Rivero R, Hoang HN, Lim XY, Deng J, McWilliam H, Villadangos JA, McCluskey J, Corbett AJ, Fairlie DP. 
Potent immunomodulators developed from an unstable bacterial metabolite of vitamin B2 biosynthesis. Angew Chem Int Ed Engl. 2024;63(31):
Article e202400632.
</cite> [<a href="https://doi.org/10.1002/anie.202400632" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38679861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Angew%20Chem%20Int%20Ed%20Engl&amp;title=Potent%20immunomodulators%20developed%20from%20an%20unstable%20bacterial%20metabolite%20of%20vitamin%20B2%20biosynthesis&amp;volume=63&amp;issue=31&amp;publication_year=2024&amp;pages=Article%20e202400632&amp;pmid=38679861&amp;doi=10.1002/anie.202400632&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<span class="label">44.</span><cite>Salminen A. 
Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process. Ageing Res Rev. 2022;75:
Article 101573.
</cite> [<a href="https://doi.org/10.1016/j.arr.2022.101573" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35085834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ageing%20Res%20Rev&amp;title=Role%20of%20indoleamine%202,3-dioxygenase%201%20(IDO1)%20and%20kynurenine%20pathway%20in%20the%20regulation%20of%20the%20aging%20process&amp;volume=75&amp;publication_year=2022&amp;pages=Article%20101573&amp;pmid=35085834&amp;doi=10.1016/j.arr.2022.101573&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<span class="label">45.</span><cite>Hong YS, Cilindre C, Liger-Belair G, Jeandet P, Hertkorn N, Schmitt-Kopplin P. 
Metabolic influence of Botrytis cinerea infection in champagne base wine. J Agric Food Chem. 2011;59(13):7237–7245.
</cite> [<a href="https://doi.org/10.1021/jf200664t" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21604814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Agric%20Food%20Chem&amp;title=Metabolic%20influence%20of%20Botrytis%20cinerea%20infection%20in%20champagne%20base%20wine&amp;volume=59&amp;issue=13&amp;publication_year=2011&amp;pages=7237-7245&amp;pmid=21604814&amp;doi=10.1021/jf200664t&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<span class="label">46.</span><cite>Tao Y, Leng SX, Zhang H. 
Ketogenic diet: An effective treatment approach for neurodegenerative diseases. Curr Neuropharmacol. 2022;20(12):2303–2319.
</cite> [<a href="https://doi.org/10.2174/1570159X20666220830102628" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9890290/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36043794/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Neuropharmacol&amp;title=Ketogenic%20diet:%20An%20effective%20treatment%20approach%20for%20neurodegenerative%20diseases&amp;volume=20&amp;issue=12&amp;publication_year=2022&amp;pages=2303-2319&amp;pmid=36043794&amp;doi=10.2174/1570159X20666220830102628&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<span class="label">47.</span><cite>Zhang Q, Meng B, Tang M, Li C, Xu Y, Pan J, Yu L, Li Y, Yang Y, Liu Y, et al. 
Activation of GPR35 by kynurenic acid inhibits IL-1beta secretion in macrophages during CR-hvKP-induced pneumonia. Int Immunopharmacol. 2025;153:
Article 114416.
</cite> [<a href="https://doi.org/10.1016/j.intimp.2025.114416" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40106903/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Immunopharmacol&amp;title=Activation%20of%20GPR35%20by%20kynurenic%20acid%20inhibits%20IL-1beta%20secretion%20in%20macrophages%20during%20CR-hvKP-induced%20pneumonia&amp;volume=153&amp;publication_year=2025&amp;pages=Article%20114416&amp;pmid=40106903&amp;doi=10.1016/j.intimp.2025.114416&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<span class="label">48.</span><cite>Mlotkowska P, Misztal T, Kowalczyk P, Marciniak E. 
Effect of kynurenic acid on enzymatic activity of the DNA base excision repair pathway in specific areas of the sheep brain. Sci Rep. 2024;14(1):
Article 15506.
</cite> [<a href="https://doi.org/10.1038/s41598-024-66094-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11226655/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38969725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Effect%20of%20kynurenic%20acid%20on%20enzymatic%20activity%20of%20the%20DNA%20base%20excision%20repair%20pathway%20in%20specific%20areas%20of%20the%20sheep%20brain&amp;volume=14&amp;issue=1&amp;publication_year=2024&amp;pages=Article%2015506&amp;pmid=38969725&amp;doi=10.1038/s41598-024-66094-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49">
<span class="label">49.</span><cite>Zheng X, Hu M, Zang X, Fan Q, Liu Y, Che Y, Guan X, Hou Y, Wang G, Hao H. 
Kynurenic acid/GPR35 axis restricts NLRP3 inflammasome activation and exacerbatescolitis in mice with social stress. Brain Behav Immun. 2019;79:244–255.
</cite> [<a href="https://doi.org/10.1016/j.bbi.2019.02.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30790702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Behav%20Immun&amp;title=Kynurenic%20acid/GPR35%20axis%20restricts%20NLRP3%20inflammasome%20activation%20and%20exacerbatescolitis%20in%20mice%20with%20social%20stress&amp;volume=79&amp;publication_year=2019&amp;pages=244-255&amp;pmid=30790702&amp;doi=10.1016/j.bbi.2019.02.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50">
<span class="label">50.</span><cite>Park S, Lee S, Nam S, Im D. 
GPR35 mediates lodoxamide-induced migration inhibitory response but notCXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptorfor CXCL17?
Br J Pharmacol. 2018;175(1):154–161.
</cite> [<a href="https://doi.org/10.1111/bph.14082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5740256/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29068046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Pharmacol&amp;title=GPR35%20mediates%20lodoxamide-induced%20migration%20inhibitory%20response%20but%20notCXCL17-induced%20migration%20stimulatory%20response%20in%20THP-1%20cells;%20is%20GPR35%20a%20receptorfor%20CXCL17?&amp;volume=175&amp;issue=1&amp;publication_year=2018&amp;pages=154-161&amp;pmid=29068046&amp;doi=10.1111/bph.14082&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51">
<span class="label">51.</span><cite>Nam S, Park S, Im D. 
Protective effect of lodoxamide on hepatic steatosis through GPR35. Cell Signal. 2019;53:190–200.
</cite> [<a href="https://doi.org/10.1016/j.cellsig.2018.10.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30304698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Signal&amp;title=Protective%20effect%20of%20lodoxamide%20on%20hepatic%20steatosis%20through%20GPR35&amp;volume=53&amp;publication_year=2019&amp;pages=190-200&amp;pmid=30304698&amp;doi=10.1016/j.cellsig.2018.10.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52">
<span class="label">52.</span><cite>Jackson-Lewis V, Przedborski S. 
Protocol for the MPTP mouse model of Parkinson’s disease. Nat Protoc. 2007;2(1):141–151.
</cite> [<a href="https://doi.org/10.1038/nprot.2006.342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17401348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Protoc&amp;title=Protocol%20for%20the%20MPTP%20mouse%20model%20of%20Parkinson%E2%80%99s%20disease&amp;volume=2&amp;issue=1&amp;publication_year=2007&amp;pages=141-151&amp;pmid=17401348&amp;doi=10.1038/nprot.2006.342&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53">
<span class="label">53.</span><cite>Dauer W, Przedborski S. 
Parkinson’s disease: Mechanisms and models. Neuron. 2003;39(6):889–909.
</cite> [<a href="https://doi.org/10.1016/s0896-6273(03)00568-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12971891/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=Parkinson%E2%80%99s%20disease:%20Mechanisms%20and%20models&amp;volume=39&amp;issue=6&amp;publication_year=2003&amp;pages=889-909&amp;pmid=12971891&amp;doi=10.1016/s0896-6273(03)00568-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54">
<span class="label">54.</span><cite>De Giovanni M, Tam H, Valet C, Xu Y, Looney MR, Cyster JG. 
GPR35 promotes neutrophil recruitment in response to serotonin metabolite 5-HIAA. Cell. 2022;185(5):815–830.e19.
</cite> [<a href="https://doi.org/10.1016/j.cell.2022.01.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9037118/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35148838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=GPR35%20promotes%20neutrophil%20recruitment%20in%20response%20to%20serotonin%20metabolite%205-HIAA&amp;volume=185&amp;issue=5&amp;publication_year=2022&amp;pages=815-830.e19&amp;pmid=35148838&amp;doi=10.1016/j.cell.2022.01.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55">
<span class="label">55.</span><cite>Nakazawa K, Sapkota K. 
The origin of NMDA receptor hypofunction in schizophrenia. Pharmacol Ther. 2020;205:
Article 107426.
</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2019.107426" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6981256/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31629007/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol%20Ther&amp;title=The%20origin%20of%20NMDA%20receptor%20hypofunction%20in%20schizophrenia&amp;volume=205&amp;publication_year=2020&amp;pages=Article%20107426&amp;pmid=31629007&amp;doi=10.1016/j.pharmthera.2019.107426&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56">
<span class="label">56.</span><cite>Choe K, Bakker L, Hove DL, Eussen SJ, Kenis G, Ramakers IH, Verhey FR, Rutten BP, Köhler S. 
Kynurenine pathway dysregulation in cognitive impairment and dementia: A systematic review and meta-analysis. Geroscience. 2025.</cite> [<a href="https://doi.org/10.1007/s11357-025-01636-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40338439/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Geroscience&amp;title=Kynurenine%20pathway%20dysregulation%20in%20cognitive%20impairment%20and%20dementia:%20A%20systematic%20review%20and%20meta-analysis&amp;publication_year=2025&amp;pmid=40338439&amp;doi=10.1007/s11357-025-01636-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57">
<span class="label">57.</span><cite>Qiu S, Palavicini JP, Wang J, Gonzalez NS, He S, Dustin E, Zou C, Ding L, Bhattacharjee A, Van Skike CE, et al. 
Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer’s disease-like neuroinflammation and cognitive impairment. Mol Neurodegener. 2021;16(1):
Article 64.
</cite> [<a href="https://doi.org/10.1186/s13024-021-00488-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8442347/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34526055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Neurodegener&amp;title=Adult-onset%20CNS%20myelin%20sulfatide%20deficiency%20is%20sufficient%20to%20cause%20Alzheimer%E2%80%99s%20disease-like%20neuroinflammation%20and%20cognitive%20impairment&amp;volume=16&amp;issue=1&amp;publication_year=2021&amp;pages=Article%2064&amp;pmid=34526055&amp;doi=10.1186/s13024-021-00488-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58">
<span class="label">58.</span><cite>Ogawa N, Hirose Y, Ohara S, Ono T, Watanabe Y. 
A simple quantitative bradykinesia test in MPTP-treated mice. Res Commun Chem Pathol Pharmacol. 1985;50(3):435–441.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/3878557/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Res%20Commun%20Chem%20Pathol%20Pharmacol&amp;title=A%20simple%20quantitative%20bradykinesia%20test%20in%20MPTP-treated%20mice&amp;volume=50&amp;issue=3&amp;publication_year=1985&amp;pages=435-441&amp;pmid=3878557&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>Supplementary 1</span><p>Tables S1 and S2</p>
<p>Figs. S1 to S8</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12376290/bin/research.0846.f1.docx" data-ga-action="click_feat_suppl" class="usa-link">research.0846.f1.docx</a><sup> (30.9MB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data are available upon reasonable request. All data are available in the main text or Supplementary Materials. Correspondence and requests for materials should be addressed to S.M. (<span>ma.shaohua@sz.tsinghua.edu.cn</span>) on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Research are provided here courtesy of <strong>American Association for the Advancement of Science (AAAS) and Science and Technology Review Publishing House</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.34133/research.0846"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/research.0846.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (16.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12376290/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12376290/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12376290%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12376290/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12376290/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12376290/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12376290/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12376290/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12376290/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="x7CX4RovzVXb6GT1WereiJdHoAUqhgyLFpGQqe6Hdrn6zuy3wzZDBvQlGo7ymUba">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
